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INTRODUCTION 
 
Siddha system of medicine is a holistic medical system which has been 
developed gradually during the consecutive era. Siddha medicine is a comprehensive 
system of medicine and this is briefly described by Siddhars.Siddhar (Sage) is a tamil 
word that is derived from its word ―Chit‖ which means “PERFECTION 
ORHEAVENLY BLISS‖.  
Ancient Siddhars had the knowledge and wisdom to find treatments to the day 
problems through single herb, Polyherbal, Herbo mineral and sometimes animal by-
products. According to the siddha science all the things in the universe both inside 
and outside the body are made up of five basic elaments namely SPACE, AIR, 
FIRE, WATER AND SOIL in balanced proportions.  
In south India siddha still remains dominant compared to modern medicine 
particularly for the treatment of a variety of chronic disease conditions among masses. 
The basic motto of siddha science is ―FOOD ITSELF A MEDICINE AND 
MEDICINE ITSELF IS FOOD’’. Siddha medicine is not only used to treat diseases. 
Apart from this it also acts as a Prophylaxis to prevent the diseases. ―An Ounce of 
Prevention is Worth a pound of cure”. There are so many ways such as 
Kayakalpam, Yoga, Pranayama…ect to prevent the diseases. Pathyam (Balanced diet) 
plays a unique role in siddha medicine to prevent further complications of the existed 
diseases. The only hope is that we should make a scientific study of Siddhars ancient 
medical works to the Enlightment of medical field. A remarkable increase in the 
usage of medicinal plant products in the form of plant extracts and their active 
components etc. Have been observed in the past decade, among the world population 
as a primary health care aid. 
One of our great Saint Yugi muni classified the diseases into 4448. AAN 
MALADU is disease one among them. According to Yugi muni in aanmaladu the 
semen exhibits the following characters such as absence of sweetness, buoyancy on 
water. He further explained the character of urine in aanmaldu as froth in urine and 
symptoms like absence of virility. 
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The most important part of siddha medicine is 7 UDAL THADHU i. e 
(SARAM, SENEER, OON, KOZHUPU, ENBU, MOOLAI, SUKKILAM, 
SURONITHAM). Sukkilam is one among the seven udalthathukkal and it is affected 
in Aanmaladu. It can be termed as with male Infertility in modern science. Most cases 
of male infertility are due to an abnormal sperm count or low sperm motility. 
Infertility is the inability of a sexually active, non-contraception couple to achieve 
pregnancy in one year. In former days Infertility is only accompanied with women. 
But nowadays due to sedentary lifestyle it is also accompanied with men. Male 
infertility is blamed in 50 % of cases where couples could not conceive naturally. 
Male infertility is a global problem in the field of reproductive health. 
Infertility bears a social stigma. In couples experiencing infertility, 
approximately 35% is due to male factors, 35% is due to female factors, 20% of cases 
have a combination of both male and female factors and the last 10% are unexplained 
causes. 
Most of the cases hail from IT back ground, chemical industry, oil refineraries, 
viral infections at an early age in male child, trauma in testes, endocrine disorder, low 
economic status, can also lead to rise in infertility rate. The heat generated from 
laptops can make an impact sperm production and development making it difficult to 
conceive down the road. As per WHO guidelines a report with count less than 20 
million / ml is oligospermia. Oligospermia is a male fertility issue defined as a low 
sperm concentration in the ejaculation. The most common problems a man facesare 
low sperm count, morphology abnormalities and motility of sperm. 
This current research study entitled Aanmaladu (Male infertility) mainly focus 
on outcome of qualitative and quantitative analysis of semen in oligospermia patients 
with the trial drug THADHU VIRUTHI KULIGAI. Thadhuviruthikuligai is a 
polyherbal compound based on the ingredients of the drug. The trial drug 
Thadhuviruthikuligai being the poly herbal formulation consists of ingredients 
possessing anti oxidants (kayakalpha drugs) and aphrodisiac properties. 
Since the trial medicines is yet to be documented for its efficacy, it is essential 
to do safety going for clinical study. 
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AIM AND OBJECTIVES 
 
Aim: 
To document the effective of Siddha Medicine Thadhu viruthi kuligai (Internal 
medicines) in the management of AAN MALADU (male infertility) 
Primary Objective: 
To evaluate the therapeutic efficacy of Thadhu viruthi kuligai 
(Internalmedicines) based on Semen analysis in the treatment of AAN MALADU 
(male infertility) 
Secondary Objective: 
 To prepare the trial Medicine as per the textNOIGALAKU SIDDHA 
MARUTHUVAPARIGARAM. 
 To collect raw drugs and to get Authentication. 
 To evaluate the phytochemical analysis of the drug. 
 To study the changes in special investigation –Semen Analysis Before 
andAfter treatment. 
 To evaluate the Infertility Percentage among the study patients with 
respect to age, occupation, and socioeconomic structure 
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ஆண்஥னடு 
“தார்க்கவ஬ஆண்஥கணின்஬ிந்து஡ானும் 
த஡஥ாண஡ி஡ிப்பு஦ில்னா஡஡ாலும் 
ஏற்கவ஬சன஥ீ஡ில்஥ி஡ந்஡஡ாலும் 
எ஫ினாகவு஦ிர்ப்தற்று஦ிபேப்த஡ாலும் 
வசர்க்கவ஬ப௄த்஡ி஧த்஡ில்த௃ர஧஡ான்வதாலும் 
சச஦னாணகபே஬துவும்஡ரிக்க஥ாட்டா 
஡ரீ்க்கவ஬பெகிப௃ணிசிகிச்சா஧ம் 
ச஡பி஬ாகப்தாடிர஬த்஡ார்஡ிந஥ி஡ாவண” 
- பெகிப௃ணி 
 
The characteristics of semen in AAN MALADU 
The presence of semen in aanmaladu is lack of sweetness and life then it will 
float on the surface of water. 
The urine also will be frothy. Such man will be incapable to give succeeding 
generation. 
 
DEVELOPMENT OF SPERM 
“உ஡஦த்஡ில்஬ிந்து஬ில்ஒங்குகுண்டனிப௅ம் 
உ஡஦குடினில்஬஦ிந்஡஬ம்ஒன்தான் 
஬ி஡ி஦ில்தி஧஥ா஡ிகள்஥ிகுசத்஡ி 
க஡ி஦ிற்க஧஠ங்கரனர஬கரிவ஦!” 
     -஡ிபேப௄னர் 
 
In the above verses Thirumolar states that the driving force of the kundalini 
arises in the sperm which in turn initates the anthakarnanam to bring changes in the 
ova during fertilization. 
 
5 ARTS OF SPERM 
1. Neekal 
2. Nelaipithal 
3. Nugarvithal 
4. Amaithiyakkal 
5. Appalakkal 
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CONFIGURATION OF SEMEN 
Based on siddha principles the semen is constituent by eighty drops of blood 
which is equal to one drop of semen. Therefore, even wasting a single drop of semen 
is equal to wasting six thousand four hundred drops of blood. 
“அ஫ிகின்ந஬ிந்துஅபர஬அநி஦ார் 
க஫ிகின்ந஡ன்ரணப௅ட்காக்கலுந்வ஡஧ார் 
அ஫ிகின்நகா஦த்஡஫ிந்஡஦ர்வுற்வநார் 
அ஫ிகின்ந஡ன்ர஥஦நிந்ச஡ா஫ி஦ாவ஧ா!” 
   --- ஡ிபேப௄னர் - தாடல் – 1936 
 
In the above verses states about the significance of sperm. In modern 
comparison the process of spermatogenesis in which the male gamete called 
spermatozoa are formed by four stages like proliferation, growth, maturation, 
transformation. 
 
SIGNIFICANCE OF SPERM 
 
“஬ிந்து஢ிரன஦நிந்துவுந்துதாப௅ங்கானம்வ஡஬஡ாந்஡஢ா஡஥துக்கு஦ிபேண்டாகிசசாந்஡
ப௃டவண஦ி஧ண்டு஥஠ிப௅஥ாகிச்வசா஡ி஥஠ி஦ாணது஬ிம்திரநப௅஥ாகி஬ந்஡஥஡ிப்திரந
஦துவும்஬ட்ட஥ாகி ஬ட்ட஥஡ி஧ண்டுபே஬ாய்஥ண்ணு஥ாகி 
அந்஡ப௃ள்ப஥ண்ணு஡ற்உப்தாய்஢ின்வந ஦ா஡ிச஦ன்நசதாபேபாணதிண்ட஥ாச்வச” 
        -அகத்஡ி஦ர் 
After the penetration of the sperm into the ovum the sperm head fuse with the 
oocytic cell to form single cell. Then it undergoes several stages of cell division to 
form an embryo. 
“஬ிழுந்஡துஇனிங்கம்஬ிரிந்஡துவ஦ாணி 
஑஫ிந்஡ப௃஡ல்ஐந்தும்ஈர஧ந்வ஡ாடுஏநிப் 
சதா஫ிந்஡புணல்பூ஡ம்வதாற்றும்க஧஠ம் 
஑஫ிந்஡த௃஡ல்உச்சிஉள்வப஑பித்஡வ஡!” 
- ஡ிபேப௄னர். 
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At the time of copulation, the semen is ejaculated. The prostatic fluid gives the 
semen as a milky appearance. In the early stages after ejaculation, the sperm remains 
immotile, possibly because of the viscosity of the coagulum. As the coagulum 
dissolves the sperm become highly motile. 
 
“ஆண்஥ிகில்ஆண்ஆகும்சதண்஥ிகில்சதண்ஆகும் 
பூண்இ஧஠சடாத்துப்சதாபேந்஡ில்அனிஆகும் 
஡ாண்஥ிகும்ஆகில்஡஧஠ிப௃ழு஡ாளும் 
தா஠஬஥ிக்கிடில்தாய்ந்஡தும்இல்ரனவ஦. 
      -஡ிபேப௄னர் 
At the time of copulation if the male dominates then it is male & if the female 
dominates then it is a female child. If the male and the female are equal then the child 
will be neutral gender or a eunuch. Here male indicates the vindhu and the female 
indicates nadham. 
 
“வ஬ர்க்கவ஬வ஬னிவதால்஬ரபந்துகாக்கும் 
஬ிந்துவுடன்தி஧ா஠஬ாப௅஬ிபக்கனாவ஥” 
-பெகிப௃ணி 
 
Abana stays outside of uterus and the prana goes along with spermatozoa and 
bisects the size of the zygote. 
 
  “உன்ணி஦கர்ப்தக்கு஫ி஦ாம்ச஬பி஦ிவன 
தன்ணி஦஢ா஡ம்தகர்ந்஡திபேத்஬ி 
஬ன்ணிப௅ம்஬ாப௅஬஥ாப௅பேஞ்சுக்கினம் 
஥ன்ணி஦ச஥ணாய்஬பர்க்குப௃஡கவ஥” 
      -஡ிபேப௄னர் 
 
The ovum consists of the element earth, whereas the sperm consist of fire and 
air. The uterine wall which nourishes it bring water and the urine cavity is of the 
element space. Therefore, in the formation embryo of five elements combine and 
create it. 
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“஬ிந்துகுடி஦ிபேந்஡஡ிபே஢ாட்ரட஬ிட்வடன் 
஥ாறுகின்நகத்஡ரிக்வகால்தட்டந்஡ணில் 
஬ிந்து஢ின்று஬ிபங்கு஢஡ிர஥஦த்துள்வப 
஬ிபங்குசு஬ா஡ிட்டாணச஬பி஦ிவன஡ான்” 
  -஡ிபே஬ள்ளு஬ர்ஞாணச஬ட்டி஦ான் 
 
The swadhittanam is to be found between the genital and navel region. The 
swadhittanam is correlated with adrenal gland which secretes testosterone. 
  
               சுக்கினம்கு஠ம் 
 
“உண்ர஥஦ாணசுக்கினப௃தா஦஥ா஦ிபேந்஡தும் 
ச஬ண்ர஥஦ாகி஢ீரிவன஬ிர஧ந்து஢ீ஧஡ாணதும் 
஡ண்ர஥஦ாணகா஦வ஥஡ரித்துபே஬஥ாணதும் 
ச஡ண்ர஥஦ாணஞாணிகள்ச஡பிந்துர஧க்கவ஬ணுவ஥” 
    -சி஬஬ாக்கி஦ர்தாடல்எண்.1236---- 
  
  In the above verses Sivavakiyaar states that the sperm moves through the 
vagina in a tricky way and mixes with the internal secretions and finally to form a 
―DEW DROP‖. This dew drop enhances the growth of ovum. 
 
Modern comparison: 
 Basic physiological concept of Sperm states that the movement of the sperm 
through the uterus is facilitated by the anti peristaltic contractions of uterine muscles 
among 200-300 million of sperm entering female genital tract in that only a few 
thousand sperm reach the spot near ovum. Among these few thousand sperm only one 
is capable for fertilization with ovum. 
 
DIAGNOSIS OF DISEASE BY CHARACTERS OF SEMEN: 
 
1. White and akin to the butter, it is excellent. 
2. White and curd, it is very good. 
3. White and akin to the milk, it is good. 
4. White and akin to the buttermilk, it is fair. 
5. Akin to the honey in colour and consistency, it is average. 
6. Akin to the ghee in colour and weight, it is poor. 
7. Akin to the toddy in colour and thickness it is poor. 
8. Akin to the water, it is very bad. 
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SIDDHA PATHOLOGY 
The subtle form of primordial elements  
1. Earth 
2. Water 
3. Fire 
4. Air 
5. Space 
 In the above the Air element aggravates the urethral pain during purulent 
discharge from urethra. 
The properties of object having the five elemental components 
1. Earth - Bulk 
2. Water –Soft, giving pleasure, coolness soaking, viscid, slimy and flowing 
of semen. 
3. Fire -Hot 
4. Air - Denselessness 
5. Space – Sharp and clear 
 
The properties of taste 
 The ill effect caused by excessive intake of saltiest food leads to a gradual loss 
of vitality and vigor. 
 The ill effect caused by excessive intake of pungent food leads to impotency 
 
Based on Five Motor Organs 
1. Mouth 
2. Legs 
3. Hands 
4. Excretory Organs 
5. Reproductive Organs - Reproductive Organs causes Ejaculation, and 
ensures pleasure on account of reproduction. 
The Ten Channels (DasaNaadi) 
1. Idakalai 
2. Pingalai 
3. Suzhumunai 
4. Siguvai 
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5. Purudan 
6. Kanthari 
7. Aththi 
8. Alampudai 
9. Sangini 
10. Gugu. 
 
 Sangini – Located in Genital Organs. 
 Gugu – Located in Anorectal region. 
 
The five kinds of Aasayams: 
1. Amarvasayam 
2. Pakirvasayam 
3. Salavasayam 
4. Malavasayam 
5. Sukkilavasayam – specified activities are semen secretion and storage. 
 
KOSAM (FIVE SHEATHS): 
1. Aanamayakosam 
2. Pranamayakosam 
3. Manomayakosam –  constituted by the Mind and the Sense organs 
4. Vingnanamayakosam 
 
EIGHT PASSIONS: 
1. Kaamam 
2. Kurotham 
3. Lopam 
4. Mokam 
5. Madham 
6. Maacharyam 
7. Idumbai 
8. Ahankaram 
*KAAMAM – Sexual desire 
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THE THREE HUMOURS 
1. Vatham 
2. Pitham 
3. Kapham 
 
VATHAM- 10 different types: 
1. Pranan 
2. Abanan 
3. Vyanan 
4. Udhyanan 
5. Samanan 
6. Nagan 
7. Koorman 
8. Kirukaran 
9. Devadhaththan 
10. Dhananjayan. 
 
Abanan      –  The downward Air. Responsible for excretion of urine, 
   faeces  and semen  
 Vyanan      –      Activates the Voluntary and involuntary muscles. 
Devadaththan –  Attributes human passions. 
 
PITHAM 5 different types: 
 
Anaandhamaya Kosam – constituted by the Prana and Reproductiom 
1. Analpasakapitham 
2. Vanna eri 
3. Aatralankai 
4. Ulloli thee 
5. Nokkazhal 
AATRALANKAI – improves Blood 
ULLOLI THEE – gives color and brightness to the skin. 
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KAPHAM – 5 different types: 
1. Ali aiyum 
2. Neerpiaiyum 
3. Suvaikaanaiyam 
4. niraivuaiyam 
5. Onriayam 
Seats of kabham- Urinary bladder, Genital organs which makes the urine and Semen 
come out of the body. 
 
SEVEN PHYSICAL CONSTITUTIONS  
1. Saarum (Chyle): This gives mental and physical perseverance.  
2. Senneer (Blood): Imparts colour to the body, nourishes the body and is 
responsible for the Ally and intellect of an individual 
3. Oon(Muscle): It gives shape to the body according to the physical activity and 
covers bone.  
4. Kozhuppu (Adipose tissue): it lubricates the joints and other parts of the body to 
function smoothly  
5. Enbu (Bone): Supports the frame and responsible for the postures and 
movements of body.  
6. Moolai(Bone marrow): It occupies the medulla of the bones and gives strength 
and softness to the muscles. 
7. Sukkilam (Sperm): It is responsible for reproduction. 
 Excess Sukilam causes love and lust towards women and urinary calculi. 
 Decreased sukkilam causes failure in reproduction, pain in the genitalia etc. 
 
FOURTEEN NATURAL URGES 
 
Semen is the one of the fourteen urges 
“சுக்கினந்஡ரண஦டக்கின் 
சு஧ப௃டணரீ்க்கட்டாகும் 
தக்க஥ாங்ரககால்சந்து 
தா஧வ஢ாய்஬஫ி஦ிநங்கும் 
஥ிக்க஥ார்வ஢ாப௅ண்டாகும் 
஥ிகுத்஡ிடும்தி஧வ஥கந்஡ான் 
஡க்கவ஡ார்வதாது஥ாகின் 
஡ரித்஡ிடும்஬ாப௅க்கூவந”   -சித்஡஥பேத்து஬ாங்கசுபேக்கம் 
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 If Semen is controlled, it leads to fever, oliguria, joint pain, urinary infection, 
spermatorrhoea, Leucorrhoea and chest pain. 
 
Significance of sperm implantation period: 
Implantation of sperm occurs few days before full moon leads to unhappiness. 
 Implantation of sperm occur six days after full moon leads to 
happiness 
 Four mugurthams before dawn is the right time to implantation of 
sperm 
 One mugurtham is equal to one and a half hour 
 
               சுக்கின஬ா஡ம் 
஬ா஡஥ாப௃டலுபேகிகவும்஬ற்நி 
஥னப௄த்஡ி஧ஞ்சிக்கிவ஦கீழ்஬ி஫ா஥ல் 
஢ா஡஥ாம்஢ாக்வகாடுப௄க்கு஡ன்ணில் 
஢ாணுக்க஥ாப௅஡ி஧ந்஡ணபே஬ிதாப௅ஞ் 
சச஦வ஬ாடுசு஬ாச஥ா஦பேசிப௅ண்டாஞ் 
சூ஡஥ாய்ச்சுக்கினந்஡ான்றுன்ணி஦ாகுந் 
துரி஦சுக்கின஬ா஡சூட்சந்஡ாவண. 
        - பெகிப௃ணி 
 
Symptoms associated with sukkilam 
In the above verses yugi muni states that 
1. Emaciation 
2. Constipation 
3. Oliguria 
4. Bleeding from the nose 
5. Phlegm accumulation due to increased kapham, breathlessness 
6. Loss of taste 
All the symptoms are associated with affected sukkilam. 
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DIFFERNTIAL DIAGNOSIS: 
          ஬ா஡உதக஡ம் 
 Numbness of joints of upper and lower limbs, increased body heat, appetite, 
excessive tiredness and inability to walk, giddiness. 
 
 த஡ி஡஬ா஡ம் 
 
 Due to over talking more pain wil be felt neck aggravated in the cervical 
plexus. Loss of sexual, general weakness, increased appetite. 
 
LINE OF TREATMENT 
        The main aim of the Siddha system is to treat and to cure Udarpini (due to 
Mukkuttram) and Manapini (due to changes in Mukkunam). Treatment is not only for 
perfect healing but also for the prevention and rejuvenation. 
       It is essential to know the disease, the aetiology, the nature of the patient, severity 
of the illness, the seasons and the time of occurrence must be observed clearly.  Line 
of treatment is as follows: 
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1. Neekkam (Treatment) 
2. Niraivu (Rejuvenation) 
3. Kaapu (Prevention) 
 
 Thiruvalluvar describes the duty of the physician, i.e. study the disease, 
aetiology, seek subsiding ways and do what is proper and effective. 
 
1) NEEKKAM (Treatment in Siddha): 
 The aim of Neekkam is based on to bring the deranged Thodams to normal 
equilibrium state. To treat the patient with internal medicine and external medicine 
  Siddha system of Medicine is based on Mukkutra Theory and hence the 
treatment is mainly aimed to bring the three thodams to equilibrium state and thereby 
restoring the physiological condition of the seven Thathus. 
 The three Thodamsorganise, regularise and integrate the body structure and 
their functions. They are always kept in a state of balance by thought, word, deed and 
food. Any imbalance will lead to disease. The imbalanced thodams are balanced by 
administrating purgatives or emetics or application of Anjanam (application on eyes) 
and followed by the appropriate systemic therapy by giving Siddha drugs.  
Before treating with the trail drug, the patients were advised to take oil bath 
with ArrakuThylam to normalize the vitiated pitham to equilibrium.The purgatives 
should be given before starting the trial to normalize the deranged Thodams to 
normal. 
 In this study the purgation is induced by giving Agasthiyarkulambu - 130 mg 
with hot water in early morning in empty stomach. 
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2) NIRAIVU (Rejuvenation): 
The word literally means the power of securing the body from the effect ofage. 
According to Siddhars science rejuvenation does not necessarily mean restoring the 
oldto youth for it may simply mean the maintenance of youth without reaching the old 
age. 
So, rejuvenation is a means for prolonging life & forms a part of immortality. 
 
T.V. Sambasivampillai, Dictionary.  
(Physical, psychological, social and economic rehabilitation  
and reassurance of Individuals are known as Niraivu). 
 
3. KAAPPU (PREVENTION): 
The prevention methods for AanMaladu are as follows: 
 Advised to take oil bath twice a week. 
 Advised to avoid smoking alcohol and using tobacco of any kind. 
 Advised to avoid sour rich food suffs.  
 
4) DIETARY RESTRICTIONS: 
 In siddha system of medicine, the importance of dietary habits also 
emphasiszed for the diseases management and prevention. This line is well 
understood in these verses, 
In diseased condition diet restrictions or paththiyam are strictly followed to 
increase the effectiveness of medicine, and to reducing the severity of diseases. This 
is given in the following verse, 
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“஡ாபிப௃பேங்ரகத்஡ர஫தூதுபம்தசரன 
஬ாபினறுகீர஧ப௅ச஢ய்஬ார்த்துண்஠ி- னாபிச஦ண 
஬ிஞ்சு஬ார்வதாகத்஡ில்஬மீ்புர஧த்஡சதண்கசபனாங் 
சகஞ்சு஬ார்தின்஬ாங்கிக்வகள்” 
     -கு஠தாடம்ப௄னிரக஬குப்பு 
 
஢றுந்஡ாபி, ஢ன்ப௃பேங்ரக, தூது஠ம், தசரன, அறுகீர஧ இ஬ற்றுள் 
஦ாவ஡னும் ஑ன்ரந புபி ஢ீக்கிச் சர஥த்து ச஢ய்வசர்த்துக் காரன஦ில் ஥ாத்஡ி஧ம் 
஢ாற்தது ஢ாள் உண்஠, ஆண்ர஥ப்சதபேகும். 
 
஡஬ிர்க்கவ஬ண்டி஦ர஬: 
 தகற்சதாழு஡ில்பு஠ர்ச்சி஦ில்ஈடுதடக்கூடாது 
 ஬஦஡ில்ப௄த்஡஥ா஡ர஧ப்பு஠஧க்கூடாது 
 சதண்கபிடத்஡ில்஥ா஡த்஡ிற்கு஑பேப௃ரந஥ட்டும்பு஠ர்ச்சி஦ில்ஈடுதடவ஬ண்டும் 
 4 ஢ாட்களுக்குஎண்ச஠ய்ப௃ழுக்குசசய்஦வ஬ண்டும் 
       -சித்஡஥பேத்து஬ாங்கசுபேக்கம் 
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THE MALE REPRODUCTIVE SYSTEM 
 
 
Male Reproductive System 
 
The functions male reproductive system: 
 To produce, maintain, and transport sperm (the male reproductive cells) and 
protective fluid (semen) 
 To discharge sperm within the female reproductive tract during sex 
 To produce and secrete male sex hormones responsible for maintaining the 
male reproductive system. 
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Function of the Male Reproductive System  
The entire male reproductive system is dependent on hormones, which are 
chemicals that regulate the activity of many different types of cells or organs. The 
primary hormones involved in the male reproductive system are follicle-stimulating 
hormone, luteinizing hormone, and testosterone. 
Follicle-stimulating hormone is necessary for sperm production 
(spermatogenesis), and luteinizing hormone stimulates the production of testosterone, 
which is also needed to make sperm. Testosterone is responsible for the development 
of male characteristics, including muscle mass and strength, fat distribution, bone 
mass, facial hair growth, voice change, and sex drive. 
Semen, which contains sperm (reproductive cells), is expelled (ejaculated) 
through the end of the penis when the man reaches sexual climax (orgasm). When the 
penis is erect, the flow of urine is blocked from the urethra, allowing only semen to be 
ejaculated at orgasm. 
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 Unlike the female reproductive system, most of the male reproductive system 
is located outside the body. These external structures include the penis, scrotum, and 
testicles. 
 
Penis:  
This is the male organ used in sexual intercourse.                                                                           
           It has three parts: 1. The root     2.The body or shaft    3.The glans. 
The root: 
It attaches to the wall of the abdomen.  
 
The body or shaft and the glans  
It is the cone-shaped part at the end of the penis. The glans, also called the 
head of the penis, is covered with a loose layer of skin called foreskin. This skin is 
sometimes removed in a procedure called circumcision. The opening of the urethra, 
the tube that transports semen and urine, is at the tip of the penis. The penis also 
contains a number of sensitive nerve endings. 
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The body of the penis is cylindrical in shape and consists of three circular 
shaped chambers. These chambers are made up of special, sponge-like tissue. This 
tissue contains thousands of large spaces that fill with blood when the man is sexually 
aroused. As the penis fills with blood, it becomes rigid and erect, which allows for 
penetration during sexual intercourse. The skin of the penis is loose and elastic to 
accommodate changes in penis size during an erection. 
 
The internal organs of the male reproductive system, are called as accessory 
organs which includes the following: 
 
 
Epididymis: 
The epididymis is a long, coiled tube that rests on the backside of each testicle. 
It transports and stores sperm cells that are produced in the testes. The job of the 
epididymis is to bring the sperm to attain maturity, since the sperms that emerge from 
the testes are immature and incapable of fertilization. During sexual arousal, some 
contractions force the sperm into the vas deferens. 
 
Vas deferens:  
The vas deferens is a long, muscular tube that travels from the epididymis into 
the pelvic cavity, just behind the bladder. The vas deferens transports mature sperm to 
the urethra. It is the tube which carries urine or sperm out of the body, in preparation 
for ejaculation. 
 
Ejaculatory ducts:  
These are formed by the fusion of the vas deferens and the seminal vesicles 
(see below). The ejaculatory ducts empty into the urethra. 
 
Urethra: 
The urethra is the tube that carries urine from the bladder to out of the body. In 
males, it has the additional function of ejaculating semen when the man reaches 
orgasm. When the penis is erect during sex, the flow of urine is blocked from the 
urethra, allowing only semen to be ejaculated at orgasm. 
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Seminal vesicles:  
The seminal vesicles are sac-like pouches that attach to the vas deferens near 
the base of the bladder. The seminal vesicles produce a sugar-rich fluid (fructose) that 
provides sperm with a source of energy to help them move. The fluid of the seminal 
vesicles makes up most of the volume of a man's ejaculatory fluid, or ejaculate. 
 
 
Prostate gland:  
The prostate gland is a walnut-sized structure that is located below the urinary 
bladder in front of the rectum. The prostate gland contributes additional fluid to the 
ejaculate. Prostate fluids also help to nourish the sperm. The urethra, which carries the 
ejaculate to be expelled , runs through the center of the prostate gland. 
 
 
Bulbourethral glands:  
Also called Cowper's glands, these are pea-sized structures located on the 
sides of the urethra just below the prostate gland. These glands produce a clear, 
slippery fluid that empties directly into the urethra. This fluid serves to lubricate the 
urethra and to neutralize any acidity that may be present due to residual drops of urine 
in the urethra. 
 
Scrotum: 
This is the loose pouch-like sac of skin that hangs behind and below the penis. 
It contains the testicles (also called testes), as well as many nerves and blood vessels. 
The scrotum acts as a "climate control system" for the testes. For normal sperm 
development, the testes must be at a temperature slightly cooler than body 
temperature. Special muscles in the wall of the scrotum allow it to contract and relax, 
moving the testicles closer to the body for warmth or farther away from the body to 
cool the temperature. 
 
Testicles (testes): 
These are oval organs about the size of large olives that lie in the scrotum, 
secured at either end by a structure called the spermatic cord. Most men have two 
testes. The testes are responsible for making testosterone, the primary male sex 
hormone, and for generating sperm. Within the testes are coiled masses of tubes 
called seminiferous tubules. These tubes are responsible for producing sperm cells. 
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SpermSperm are made in hundreds of microscopic tubes, known as seminiferous 
tubules, which make up most of the  testicles.  
 Surrounding these tubules are clumps of tissue containing Leydig cells, which 
produce testosterone when stimulated by luteinizing hormone (LH). 
 Sperm Development. The life cycle of sperm takes about 74 days: 
 Sperm in the begining partially embedded in nurturing Sertoli cells, which are 
located in the lower parts of the seminiferous tubules. 
 
As they mature move along, and are stored in the upper part of the 
seminiferous tubules. Young sperm cells are known as spermatids. 
 
When the sperm has completed the development of its head and tail, it is 
released from the cell into the epididymis. This C-shaped tube is 1/300 of an inch in 
diameter and about 20 feet long. It loops back and forth on itself within a space that is 
only about one and a half inches long. The sperm's journey through the epididymis 
takes about 3 weeks. 
 
 The fluid in which the sperm is transported contains sugar in the form of 
fructose, which provides energy as the sperm matures. In the early stages of its 
passage, the sperm cannot swim in a forward direction and can only vibrate its tail 
weakly. By the time the sperm reaches the end of the epididymis, however, it matures 
and looks like a microscopic squirming tadpole. 
 
 At maturity, each healthy sperm consists of a head that contains the man's 
genetic material (his DNA) and a tail that lashes back and forth at great speed to 
propel the head forward at about four times its own length every second. The ability 
of a sperm to move forward rapidly and straight is probably the most significant 
determinant of male fertility. 
 
 Ejaculation. When a man experiences sexual excitement, nerves stimulate the 
muscles in the epididymis to contract, which forces the sperm out through the penis: 
 
 After being produced in the testicle, the sperm first pass through the 
epididymis and then into one of two rigid and wire-like muscular channels, called the 
vasa deferentia. (A single member of this pair of channels is called a vas deferens.) 
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 Muscle contractions in the vas deferens from sexual activity propel the sperm 
along past the seminal vesicles. These are clusters of tissue that contribute fluid, 
called seminal fluid, to the sperm. The vas deferens also collects fluid from the nearby 
prostate gland. This mixture of various fluids and sperm is the semen. 
 
 Each vas deferens then joins together to form the ejaculatory duct. This duct, 
which now contains the sperm-containing semen, passes down through the urethra. 
(The urethra is the same channel in the penis through which a man urinates, but 
during orgasm, muscles close off the bladder so that urine cannot enter the urethra.) 
The semen is forced through the urethra during ejaculation, the final stage of orgasm 
when the sperm is literally shot out of the penis. 
 
Sperm Abnormalities 
 
Sperm abnormalities can be caused by a range of factors, including congenital 
birth defects, disease, chemical exposure, and lifestyle habits. In many cases, the 
causes of sperm abnormalities are unknown. 
 
Sperm abnormalities are categorized by whether they affect sperm count, 
sperm movement, or sperm shape. They include: 
 
Low Sperm Count (Oligospermia)  
 
Sperm count of less than 20 million/mL is considered as Azoospermia refers 
to the complete absence of sperm cells in the ejaculate. Partial obstruction anywhere 
in the long passages through which sperm pass can reduce sperm counts. Sperm count 
varies widely over time, and temporary low counts are common. A single test that 
reports a low count may not be a representative result. 
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Poor Sperm Motility (Asthenospermia) 
 
Sperm motility is the sperm's ability to move. If movement is slow or not in a 
straight line, the sperm have difficulty invading the cervical mucus or penetrating the 
hard-outer shell of the egg. If 60% or more of sperm have normal motility, the sperm 
is said to be average in quality. If less than 40% of sperm are able to move in a 
straight line, the condition is considered abnormal. Sperm that move sluggishly may 
have genetic or other defects that render them incapable of fertilizing the egg. Poor 
sperm motility may be associated with DNA fragmentation and may increase the risk 
for passing on genetic diseases. 
 
Abnormal Sperm Morphology (Teratospermia) 
 
Morphology refers to shape and structure. Abnormally shaped sperm cannot 
fertilize an egg. About 60% of the sperm should be normal in size and shape for 
adequate fertility. The perfect sperm structure is an oval head and long tail. 
 
In addition to providing the fluid that transports the sperm, semen also has 
other benefits: 
 
It provides a very short-lived alkaline environment to protect sperm from the 
harsh acidity of the female vagina. (If the sperm do not reach the woman's cervix 
within several hours, the semen itself becomes toxic to sperm and they die.) 
 
It contains a gelatin-like substance that prevents it from draining from the 
vagina too quickly. 
 
It contains sugar in the form of fructose to provide instant energy for sperm 
locomotion. 
 
The sperm's passage to the egg is a difficult journey. Semen provides the 
pathway for the sperm to reach the egg. 
 
Usually about 100 - 300 million sperm are delivered into the ejaculate at any 
given time. Even under normal conditions only about 15% of these millions of sperm 
are strong enough to fertilize an egg. 
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After the stress of ejaculation, only about 400 sperm survive the orgasm to 
continue the journey. 
 
Out of this number, only about 40 sperm survive the challenges posed by the 
semen and the environment of the vagina to reach the vicinity of the egg. Normally, 
the cervical mucus forms an impenetrable barrier to sperm. However, when a woman 
ovulates (releases her egg, the oocyte), the mucous lining thins to allow sperm 
penetration. 
 
Sperm that manage to reach the mucus lining in the woman's cervix (the lower 
part of her uterus) must survive about four more days to reach the woman's fallopian 
tubes. (Here, the egg is positioned for fertilization for only 12 hours each month.) 
 
The few remaining sperm that penetrate the cervical mucus and are able to 
reach the fallopian tubes become capacitated. 
 
Capacitation is a one-time explosion of energy that completes the sperm's 
journey. It boosts the motion of the sperm and triggers the actions of the acrosome, a 
membrane that covers the head of the sperm and resembles a warhead. The acrosome 
is dissolved, and enzymes contained within it are released to allow the sperm to drill a 
hole through the tough outer coating of the egg. 
 
In the end, only one sperm gets through to fertilize the egg 
 
Testosterone 
 A testosterone test checks the level of this male hormone (androgen) in the 
blood. Testosterone affects sexual features and development. In men, it is made in 
large amounts by the testicles. In both men and women, testosterone is made in small 
amounts by the adrenal glands; and, in women, by the ovaries. 
 
 The pituitary gland controls the level of testosterone in the body. When the 
testosterone level is low, the pituitary gland releases a hormone called luteinizing 
hormone (LH). This hormone tells the testicles to make more testosterone. 
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 Before puberty, the testosterone level in boys is normally low. Testosterone 
increases during puberty. This causes boys to develop a deeper voice, get bigger 
muscles, make sperm, and get facial and body hair. The level of testosterone is the 
highest around age 40, then gradually becomes less in older men. 
 
 In women, the ovaries account for half of the testosterone in the body. Women 
have a much smaller amount of testosterone in their bodies compared to men. But 
testosterone plays an important role throughout the body in both men and women. It 
affects the brain, bone and muscle mass, fat distribution, the vascular system, energy 
levels, genital tissues, and sexual functioning. 
 
 Most of the testosterone in the blood is bound to a protein called sex hormone 
binding globulin (SHBG). Testosterone that is not bound ("free") can also be checked 
if a man or a woman is having sexual problems. 
 
Significance of testosterone: 
 A low amount of testosterone can lead to low sperm counts. 
 A low level of testosterone may lower a man's sex drive or not allow him to 
have an erection (erectile dysfunction). 
 See whether a high level of testosterone is causing a boy younger than age 10 
to have early signs of puberty. 
 Check a decreased sex drive in a woman. This may be due to the level of 
testosterone in her body. 
 Find out why a woman is developing male features, such as excessive facial 
and body hair (hirsutism) and a deep voice. 
 Find out why a woman is having irregular menstrual periods. 
 See if testosterone-lowering medicines are working in a man with 
advancedprostate cancer. 
 Find the cause of osteoporosis in a man. 
 
A testosterone test checks the level of androgen (male sex hormone) in the blood. 
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Normal 
The normal values listed here-called a reference range-are just a guide. These 
ranges vary from lab to lab, and your lab may have a different range for what’s 
normal.  
Table: 1 
Total testosterone 
Men 270-1070 ng/dL (9-38 nmol/L) 
Women 15-70 ng/dL (0.52-2.4 nmol/L) 
Children 2-20 ng/dL or 0.07-0.7 nmol/L 
 
The testosterone level for a postmenopausal woman is about half the normal level for 
a healthy, nonpregnant woman. And a pregnant woman will have 3 to 4 times the 
amount of testosterone compared to a healthy, nonpregnant woman. 
 
Table: 2 
Free testosterone 
Men 50-210 pg/mL (174-729 pmol/L) 
Women 1.0-8.5 pg/mL (3.5-29.5 pmol/L) 
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The etiologic factors in male infertility continue to be debated and there is 
incomplete knowledge about its pathophysiology.  
 
A varicocele develops when the one way valves in these spermatic veins are 
damaged causing an abnormal back flow of blood from the abdomen into the scrotum 
creating a hostile environment for sperm development.  Varicocoeles may cause 
reduced sperm count and abnormal sperm morphology which cause infertility.  
Variococles can usually be diagnosed by a physical examination of the scrotum which 
can be aided by the Doppler stethoscope and scrotal ultrasound.  Varicocoele can be 
treated in many ways but the most successful treatments involve corrective surgery. 
 
INVESTIGATION 
1.Semen sample 
 A semen sample is collected by masturbation. Patient is adviced to urinate and 
then wash and rinse their hands and penis before collecting the semen in a sterile cup. 
Lubricants or condoms should not be used when collecting the sample. While collect 
the semen sample at home, be sure to get it to the lab or clinic within 1 hour. Keep the 
sample at body temperature and out of direct sunlight. The sample cannot be collected 
by having sexual intercourse and then withdrawing when you ejaculate because 
vaginal fluid may be mixed with the sperm. 
 
2.Collection of Semen 
 Patient was asked to avoid any sexual activity that results in ejaculation for 2 
to 5 days before a semen analysis. This helps to ensure that sperm count will be at its 
highest, and it improves the reliability of the test. If possible, do not avoid sexual 
activity for more than 1 to 2 weeks before this test, because a long period of sexual 
inactivity can result in less active sperm. 
 
Patient was asked to avoid drinking alcohol for a few days before the test. The 
most common way to collect semen is by masturbation, directing the semen into a 
clean sample cup. Do not use a lubricant. 
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Patient was advised to collect a semen sample during sex by withdrawing their 
penis from their partner just before ejaculating (coitus interruptus). patient then 
ejaculate into a clean sample cup. This method can be used after a vasectomy to test 
for the presence of sperm, but other methods will likely be recommended if you are 
testing for infertility. 
 
Sperm collection by surgical method:  
 
 If sperm cannot be collected by means of masturbation, they are surgically 
removed from a testicle through a small incision. This method of sperm retrieval is 
done when there is a blockage that prevents sperm from being ejaculated or when 
there is a problem with sperm development. To screen for possible genetic problems 
that could affect offspring, experts recommend that men with little or no sperm in 
their semen (not due to a blockage) have genetic testing before they proceed with 
ICSI. 
 
3. Sperm Penetration Tests 
 
 Sperm penetration tests were check carried out to whether a man's sperm can 
move through cervical mucus and the fallopian tubes to join with (fertilize) an egg. 
This test is usually done when a couple is having trouble becoming pregnant 
(infertility). 
 
SEMEN ANALYSIS 
Volume   : This is a measure of how much semen is present in one 
    ejaculation. 
Liquefaction time  : Semen is a thick gel at the time of ejaculation and  
    normally becomes liquid within 20 minutes after  
    ejaculation. Liquefaction time is a measure of the time 
    taken by the semen to liquefy. 
  
Sperm count   : This is a count of the number of sperm present per  
    milliliter (mL)of semen in one ejaculation. 
Sperm morphology  : This is a measure of the percentage of sperm that have a 
    normal shape. 
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Sperm motility  : This is a measure of the percentage of sperm that can 
    move forward normally. The number of sperm that  
    show normal forward movement in a certain amount of 
    semen can also be measured (motile density). 
 
pH    : This is a measure of the acidity (low pH) or alkalinity 
    (high pH) of the semen. 
White blood cell :  White blood cells are not normally present in semen. 
count 
 
Fructose level  : This is a measure of the amount of a sugar called  
    fructose in the semen. The fructose provides energy for 
    the sperm.  
 
Significance of Semen Analysis: 
A semen analysis is done to determine whether: 
• A man has a reproductive problem that is causing infertility. 
• A vasectomy has been successful. 
• The reversal of a vasectomy has been successful. 
 
Intracytoplasmic Sperm Injection for Infertility 
 
Intracytoplasmic sperm injection (ICSI) is an assisted reproductive technology 
(ART) used to treat sperm-related infertility problems. ICSI is used to enhance the 
fertilization phase of in vitro fertilization (IVF) by injecting a single sperm into a 
mature egg. The fertilized egg is then placed in a woman's uterus or fallopian tube. 
 
4.Antisperm Antibody Test 
 
 An antisperm antibody test looks for special proteins (antibodies) that fight 
against a man's sperm in blood, vaginal fluids, or semen. The test uses a sample of 
sperm and adds a substance that binds only to affected sperm. 
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Semen can cause an immune system response in either the man's or woman's 
body. The antibodies can damage or kill sperm. If a high number of sperm antibodies 
come into contact with a man's sperm, it may be hard for the sperm to fertilize an egg. 
The couple has a hard time becoming pregnant. This is called immunologic infertility. 
 
A man can make sperm antibodies when his sperm come into contact with his 
immune system. This can happen when the testicles are injured or after surgeries 
(such as a biopsy or vasectomy) or after a prostate gland infection. The testicles 
normally keep the sperm away from the rest of the body and the immune system. 
 
A woman can have an allergic reaction to her partner's semen and make sperm 
antibodies. This kind of immune response is not fully understood but may affect 
fertility. This is a rare cause of infertility. 
 
Significance of Antisperm antibody test 
 
The antisperm antibody test may be done if: A cause for infertility cannot be found. 
Experts disagree about the usefulness of the test because the result may not change the 
treatment. 
 
The results from another fertility test, such as the postcoital test, are not clear. 
An antisperm antibody test looks for special proteins (antibodies) that fight against a 
man's sperm in blood, vaginal fluids, or semen. The higher the level of antibody-
affected sperm found in the semen, the lower the chance of the sperm fertilizing an 
egg. 
 
Medical causes for Male infertility 
 Problems with male fertility can be caused by a number of health issues and 
medical treatments. More than 90% of male infertility cases are due to low sperm 
counts, poor sperm quality, or both. The remaining cases of male infertility can be 
caused by a number of factors including anatomical problems, hormonal imbalances, 
and genetic defects 
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 Varicocele: A varicocele is a swelling of the veins that drain the testicle. It's a 
common cause of male infertility. This may prevent normal cooling of the testicle, 
leading to reduced sperm count and fewer moving sperm. 
 
Infection:  
 
 Some infections can interfere with sperm production or sperm health, or can 
cause scarring that blocks the passage of sperm. These include some sexually 
transmitted infections, including chlamydia and gonorrhea; inflammation of the 
prostate (prostatitis); and inflamed testicles due to mumps (mumps orchitis). 
 
Ejaculation issues:  
 
 Retrograde ejaculation occurs when semen enters the bladder during orgasm 
instead of emerging out the tip of the penis. Various health conditions can cause 
retrograde ejaculation, including diabetes, spinal injuries, medications, and surgery of 
the bladder, prostate or urethra. Some men with spinal cord injuries or certain diseases 
can't ejaculate semen, even though they still produce sperm. 
 
Antibodies that attack sperm:  
  
 Anti-sperm antibodies are immune system cells that mistakenly identify sperm 
as harmful invaders and attempt to eliminate them. 
 
Tumors:   
 
Cancers and nonmalignant tumors can affect the male reproductive organs 
directly or can affect the glands that release hormones related to reproduction, such as 
the pituitary gland. In some cases, surgery, radiation or chemotherapy to treat tumors 
can affect male fertility. 
 
Undescended testicles:  
 
In some males, during fetal development one or both testicles fail to descend 
from the abdomen into the sac that normally contains the testicles (scrotum). 
Decreased fertility is more likely in men who have had this condition. 
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Hormone imbalances:  
 
Infertility can result from disorders of the testicles themselves or an 
abnormality affecting other hormonal systems including the hypothalamus, pituitary, 
thyroid and adrenal glands. Low testosterone (male hypogonadism) and other 
hormonal problems have a number of possible underlying causes. 
 
Sperm duct defects:  
 
The tubes that carry sperm (sperm ducts) can be damaged by illness or injury. 
Some men experience blockage in the part of the testicle that stores sperm 
(epididymis) or a blockage of one or both of the tubes that carry sperm out of the 
testicles. Men with cystic fibrosis and some other inherited conditions may be born 
without sperm ducts altogether. 
 
Chromosome defects:  
 
Inherited disorders such as Klinefelter's syndrome — in which a male is born 
with two X chromosomes and one Y chromosome (instead of one X and one Y) — 
cause abnormal development of the male reproductive organs. Other genetic 
syndromes associated with infertility include cystic fibrosis, Kallmann's syndrome, 
Young's syndrome and Kartigener syndrome. 
 
Problems with sexual intercourse:  
 
These can include trouble keeping or maintaining an erection sufficient for sex 
(erectile dysfunction), premature ejaculation, painful intercourse, anatomical 
abnormalities such as having a urethral opening beneath the penis (hypospadias), or 
psychological or relationship problems that interfere with sex. 
 
Celiac disease:  
 
A digestive disorder caused by sensitivity to gluten, celiac disease can cause 
male infertility. Fertility may improve after adopting a gluten-free diet. 
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Certain medications:  
 
Testosterone replacement therapy, long-term anabolic steroid use, cancer 
medications (chemotherapy), certain antifungal medications, some ulcer drugs and 
certain other medications can impair sperm production and decrease male fertility. 
 
Environmental causes:  
 
Over exposure to certain environmental elements such as heat, toxins and 
chemicals canreduce sperm production or sperm function. Specific causes include: 
 
Industrial chemicals:  
 Extended exposure to benzenes, toluene, xylene, pesticides, herbicides, 
organic solvents, painting materials and lead may contribute to low sperm counts. 
 
Heavy metal exposure:  
 Exposure to lead or other heavy metals also may cause infertility. 
 
Radiation or X-rays:  
 
Exposure to radiation can reduce sperm production, though it will often 
eventually return to normal. With high doses of radiation, sperm production can be 
permanently reduced. 
 
Exposure to Heat:  
 
Frequent use of saunas or hot tubs may temporarily lower your sperm count. 
Sitting for long periods, wearing tight clothing or working on a laptop computer for 
long stretches of time also may increase the temperature in your scrotum and slightly 
reduce sperm production. The type of underwear you wear is unlikely to make a 
significant difference in male fertility 
 
HEALTH, LIFESTYLE AND OTHER CAUSES 
Some other causes of male infertility include: 
 
 
Illegal drug use: Anabolic steroids taken to stimulate muscle strength and 
growth can cause the testicles to shrink and sperm production to decrease. Use of 
cocaine or marijuana may temporarily reduce the number and quality of your sperm 
as well. 
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Alcohol Use:  
 
Drinking alcohol can lower testosterone levels, cause erectile dysfunction and 
decrease sperm production. Liver disease caused by excessive drinking also may lead 
to fertility problems. 
 
Occupation:  
 
Certain occupations can increase your risk of infertility, including those 
associated with extended use of computers or video display monitors, shift work, and 
work-related stress. 
 
Tobacco smoking:  
 
Men who smoke may have a lower sperm count than do those who don't 
smoke. Secondhand smoke also may affect male fertility. 
 
Emotional stress:  
  
Stress can interfere with certain hormones needed to produce sperm. Severe or 
prolonged emotional stress, including problems with fertility, can affect your sperm 
count. 
 
Weight:  
Obesity can cause hormone changes that reduce male fertility. 
 
Prolonged bicycling:  
 
Prolonged bicycling is another possible cause of reduced fertility due to 
overheating the testicles. In some cases, bicycle seat pressure on the area behind the 
testicles (perineum) can cause numbness in the penis and erectile hormonal 
deficiencies. 
 
Hypogonadism is the general name for a severe deficiency in gonadotropin-
releasing hormone (GnRH), the primary hormone that signals the process leading to 
the release of testosterone and other important reproductive hormones. Low levels of 
testosterone from any cause may result in defective sperm production. 
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PSYCHOLOGICAL/PHYSICAL/BEHAVIORAL PROBLEMS 
 
Several sexual problems both psychological and physical in nature.  It is 
difficult to separate the physiological and physical components exist that can affect 
male fertility.    
 
Erectile dysfunction(ED):  
  
   ED is the result of a single, or more commonly a combination of multiple 
factors.  In the past, ED was thought to be the result of psychological problems, but 
new research indicates that 90 percent of cases are organic in nature.  However, most 
men who suffer from ED have a secondary psychological problem that can worsen the 
situation like performance anxiety, guilt, and low self-esteem.   
 
Common causes of impotence include:  
 
 Diabetes, high blood pressure, heart and vascular disease, stress, hormone 
problems, pelvic surgery, trauma, venous leak. 
 
Premature Ejaculation:  
 
 It is defined as an inability to control the ejaculatory response for at least thirty 
seconds following penetration.  Premature ejaculation becomes a fertility problem 
when ejaculation occurs before a man is able to fully insert his penis into his partner’s 
vagina.  Premature ejaculation can be overcome by artificial insemination or by using 
a behavioral modification technique called the ―squeeze technique‖ which 
desensitizes the penis. 
 
Ejaculatory Incompetence:  
 
 This rare psychological condition prevents men from ejaculating during sexual 
intercourse even though they can ejaculate normally through masturbation.  This 
condition sometimes responds well to behavioral therapy; if this technique does not 
work, artificial insemination can be employed using an ejaculate from masturbation. 
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RISK FACTORS REGARDING MALE INFERTILITY 
A number of risk factors are linked to male infertility. They include: 
• Smoking tobacco 
• Using alcohol 
• Using certain illegal drugs 
• Being overweight 
• Having certain past or present infections 
• Being exposed to toxins 
• Overheating the testicles 
• Having a prior vasectomy or vasectomy reversal 
• Being born with a fertility disorder or having a blood relative with a 
fertility disorder 
• Having certain medical conditions, including tumors and chronic 
illnesses 
• Taking certain medications or undergoing medical treatments, such 
surgery or radiation used for treating cancer 
• Performing certain prolonged activities such as bicycling or horseback 
riding, especially on a hard seat or poorly adjusted bicycle 
 
Complications of Male infertility 
Infertility can be stressful for both male and female. Complications can include: 
• Surgery or other procedures to treat an underlying cause of low sperm 
count or other reproductive problems 
• Expensive and involved reproductive techniques such as in vitro 
fertilization 
• Stress and relationship difficulties related to the inability to have a 
child 
 
LIFESTYLE CHANGES 
Timing and Monitoring Sexual Activity for Best Results  
Both male and female hormone levels fluctuate according to the time of day, 
and they also vary from day to day and month to month. Some timing tips might be 
helpful. 
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Fertility and Seasonal Changes.  
 
Some studies have reported higher sperm counts in the winter than in the 
summer. For women, fertility rates as measured by treatment success are highest in 
months when days are longest. 
 
Monitoring Basal Body Temperature.  
 
To determine the most likely time of ovulation and therefore the time of 
fertility, a woman should take her body temperature, called her basal body 
temperature. This is the body's temperature as it rises and falls in accord with 
hormonal fluctuations. 
  
By studying the temperature patterns after a few months, couples can begin to 
anticipate ovulation and plan their sexual activity accordingly. 
  
Frequency of Intercourse.  
 
It is not clear how often a couple should have intercourse in order to conceive. 
Some doctors think that having sex more than 2 days a week adds no benefits. In 
addition, frequent sexual activity lowers sperm count per ejaculation. Some studies 
have indicated, however, that having intercourse every day, or even several times a 
day, before and during ovulation, improves pregnancy rates. Although sperm count 
per ejaculation is low, a constantly replenished semen supply is more likely to result 
in a fertilized egg. 
 
Dietary Considerations:  
 
Everyone should eat a healthy diet rich in fresh fruits, vegetables, and whole 
grains. Replace animal fats with monounsaturated oils, such as olive oil. Certain 
specific nutrients and vitamins have been studied for their effects on male infertility 
and sperm health. They include antioxidant vitamins (vitamin C, vitamin E) and the 
dietary supplements L-carnitine and L-acetylcarnitine. To date, there is no conclusive 
evidence that they are effective. 
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NUTRITIONAL CONSIDERATIONS 
Vitamin c and other Anti- oxidants 
  
Free radical or oxidative damage to sperm is thought to be responsible for 
many cases of idiopathic oligospermia, with high levels of free radicals found in the 
semen of 40% infertile men. Three factors combine to render sperm particularly 
susceptible to free radical damage. 
 
 A high membrane concentration of polysaturated fatty acids 
 Active generation of free radicals 
 
A lack of defensive enzymes. 
 
                The health of the sperm critically dependent upon antioxidants. Although 
most free radicals are produced during normal metabolic processes, the environment 
contributes greatly to the free radical load. Men exposed to increased levels of source 
of free radicals are much more likely to have abnormal sperm and sperm counts. 
 
 Sperm extremely sensitive to free radicals because they are so dependent upon 
the integrity and fluidity of their cell membrane for proper function. Without proper 
membrane fluidity, enzymes are activated, which can lead to impaired motility, 
abnormal structure loss of viability and ultimately death of sperm. The major 
determinant of membrane fluidity is the concentration of polyunsaturated fatty acids, 
particularly omega-3 fatty acids which are very susceptible to free radical damage. 
The sperm have a relative lack of super oxide dismutase and catalase which can 
prevent oxidative damage. 
 
 A common source of oxide is cigarette smoking, which is associated with 
decreased sperm counts and sperm motility as well as increased frequency of 
abnormal sperm. Increase in environmental pollution, is thought to be a major 
contributor to the decreased in sperm counts seen in many industrialized nations. Anti 
oxidants such as vitamin C, beta carotene, selenium and vitamin E have been shown 
to be very important in protecting sperm against damage. Vitamin C plays a vital role 
in protecting the sperm’s genetic material (DNA) from damage. Ascorbic acid levels 
are much higher in seminal fluid compared with other body fluids. When dietary 
vitamin C was reduced from 250 to 5mg/ day in healty human subjects, the seminal 
fluid ascorbic acid decreased by 50% and the number of sperm with damage of DNA 
increased by 91%. 
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 It is well documented that cigarette smoking greatly reduces vitamin C levels 
throughout the body. Vitamin E has been shown to play an essential role in inhibiting 
free radical damage to the unsaturated fatty acids of the sperm membrane. Vitamin E 
enhances the ability of sperm to fertilize an egg in test tubes. 
 
Fats and oils  
 Saturated fats, hydrogenated oils, trans-fatty acids, cotton seed, coconut and 
palm oil should be avoided. Coconut and palm oils are primarily saturated fat, while 
cotton seed may contain toxic residues, due to heavy spraying of cotton and its high 
levels of gossypol, a substance known to inhibit the sperm function. Infact, gossypol 
is being investigated as the ―male birth control pill‖. Its use as an antifertility agent 
began after studies demonstrated that men who had used crude cotton seed oil as their 
cooking oil were shown to have low sperm counts followed by total testicular failure. 
Excessive consumption of saturated fats combined with inadequate intake of essential 
fatty acids changes the fatty acid composition of sperm membranes, thus decreasing 
fluidity and interfering with sperm motility.  
 
 The patient must be informed to read food labels carefully and avoid all 
sources of cotton seed oil and other damaging oils. While the in take of saturated and 
hydrogenated fats must be eliminated, the intake of polyunsaturated oils should be 
increased. These oils function in all aspects of sexual function including sperm 
formation and activity much lower in infertile men with low sperm counts, including 
that a low zinc status may be the contributing factor to the infertility. Zinc is found in 
whole grains, legumes, nuts and seeds. 
 
Vitamin B12 
 Vitamin B12 is involved in cellular replication. A deficiency of vitamin B12 
leads to reduced sperm counts and sperm motility.  
 
Arginine  
 The amino acids arginine is required for the replication of cells, making it 
essential in sperm formation.  
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Carnitine 
 Carnitine is essential in the transport of fatty acids in to the mitochondria. A 
deficiency of carnitine results in a decrease in fatty acid concentrations in the 
mitochondria and reduced energy production. Carnitine concentrations are extremely 
high in the epididymis and sperm, suggesting a role for carnitine in male reproductive 
function. The epididymis derives the majority of its energy requirements from fatty 
acids, as do the sperm, during transport through the epididymis. after the ejaculation, 
the motility of sperm correlates directly with carnitine content.  
 
 The higher the carnitine content, the more motile are the sperm. 
Supplementing th diet with L- carnitine may be useful in restoring male fertility 
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BACK GROUND: 
 
In 20th century usage of herbal based medicinal therapy gained importance 
and found their place in 40% of prescription because of their lesser side effects 
compared with other modern drugs. The usage of medicinal plant products in the form 
of plant extracts and their active components etc 
 
Yugi muni had done a lot of contribution to the siddha system, includes the 
classification of disease into 4448. AAN MALADU is one among them. According to 
Yugi muni in Aanmaladu the semen exhibits the following characters such as absence 
of sweetness, buoyancy on water. He further explained the character of urine in 
Aanmaldu as froth in urine and symptoms like absence of virility. Sukkilam one 
among the seven udalthathukkal is affected in Aanmaladu. 
 
 Infertility bears a social stigma. The incidence of infertility is follows males - 
40% females- 40% and both sex -20%. Aanmaladu is a disease known as male 
Infertility in modern science. Most cases of male infertility are due to an abnormal 
sperm, abnormal sperm count and low sperm motility.  Infertility is the inability of a 
sexually active, non-contraception couple to achieve pregnancy in one year. As per 
WHO guidelines a report with count less than 15 million / ml is oligospermia.  There 
was a time when infertility was only limited to women. In present scenario male 
infertility is blamed in 50 % of cases where couples could not conceive naturally.  
Male infertility is a global problem in the field of reproductive health. Most of the 
cases hailing from IT back ground, chemical industry, oil refineraries, other than 
occupation viral infection during childhood (ex mumps) endocrine disorder, 
trauma(testes) low economic standards, are predispose to increase the rate of 
infertility.  
 
The research study entitled Aanmaldu (Male infertility) mainly focus on 
outcome of qualitative and quantitative analysis of semen in oligospermia patients 
with the trial drug Thathuvirthikuligai. Thathuvirthikuligai is a poly herbal Siddha 
formulation.  
Neermullivirai [hygrophilla Auriculata], poonaikalivithuchooranam 
[mucunapruriens], nillapanaikilanguchooranam [curculigoorchinoids] 
thaneervittankilanguchooranam [Asparagus resimosus], karuvelampattai poo, pisin 
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[acacia nilotica], lime juice [citroslimon] and red illaneer are the ingridients present in 
this formulation.  Spermatogenic, diuretic and aphrodisiac action of ingridients 
present in this formulation were documented in various research articles. 
 
 Since the trial medicines is yet to be documented for its efficacy in 
Aanmaladu. 
 
OBJECTIVE:  
Primary objective:   
To evaluate the therapeutic efficacy of siddha formulation 
―Thathuvirthikuligai‖ in the treatment of AAN MALADU (male infertility) 
 
Secondary objective:   
To study and siddha parameter such as cofactors such as, occupations, socio 
economic status, dietary and influence.etc 
 
STUDY DESIGN & CONDUCT OF STUDY: 
 
Study type : An open clinical trial 
Study place  : OPD of Ayothidasspandithar hospital, National Institute of Siddha,    
  Tambaram sanatorium, Chennai-47. 
Study period  : 12 months 
Sample size  : 40 patients  
 
TREATMENT: 
MEDICINE NAME: 
           “THATHU VIRUTHI KULIGAI”     
 Ref  :  NOIKALUKU SIDDHA PARIKARAM 
 Author: Dr.M. SHANMUGAVELU H.P.I.M: 2
st
 Edition, pg no 165 
  
DOSAGE  : One maathirai(325mg) twice a day After food  
ADJUVANT : Cow’s Milk 
DURATION : 48 days  
ROUTE OF DRUG ADMINISTRATION: Oral route   
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STANDARD OPERATING PROCEDURE OF THE TRIAL DRUG - 
“THATHU VIRTHI KULIGAI”   
SOURCE OF RAW DRUGS:  
           The required raw drugs for the preparation of   Thathuviruthikuligai will be 
purchased from a well reputed country shop. The raw drugs will be authenticated by 
the Asst. Prof of medicinal botany at NIS. Then the raw drugs will be purified as 
mentioned in siddha literature. The medicine is prepared in Gunapadam lab of 
National Institute of Siddha. 
 
REQUIRED RAW DRUGS: 
1. Neermullivirai [Hygrophilaauriculata], Linn Dc) 
2. Poonaikallivithuchooranam [mucunapruriens], Linn) 
3. Thanneervittankizhangu (Asparagus racemosus, Wild) 
4. Nillapanaikilanguchooranam [curculio orchinoids], Dc) 
5. Karuvellampattai flowers, pisin [acacia Nilotica], Linn) 
6. Lime fruit juice [citrus limon] and 
Red illaneer 
 
METHOD OF PURIFICATION:  
 
1. POONAI KALI (Mucunapruiens, Linn Dc) 
a. Part used: Seed 
b. Fry the seeds in a mud vessel. 
2. NEERMULLI [Hygrophilaauriculata], 
a. Part used: Seed 
b. Fry the seeds in a mud vessel. 
3. THANEER VITTAN (Asparagus racemosus, Wild.) 
a. Part used: Root tuber 
b. Wash the root tuber with running water and dry it. 
4. NILAPPANAI KIZHANGU   
a. Part used: Root tuber 
b. Wash the root tuber with running water and dry it. 
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5. KARUVEL- 
a. Part used: Flower, leaves and gum 
b. Dry all the above in shade and powder it. 
 
PREPARATION: 
 All these five ingridients are soaked in Lime Fruit Juice for a day, then rubbed 
in a kalvam with the same lime juice for 2or3 days then allowed to dry, again rubbed 
with Red illaneer for another 2or 3days and till it is waxy consistency. it is rounded in 
to pills of 5 grains or about the size of illanthaivirai and dried in the shade. 
 
DRUG STORAGE:  
The trial drug ―THATHU VIRUTHI KULIGAI‖ (internal) is stored in clean 
and dry wide mouthed glass bottles. 
 
DISPENSING:   
 The prepared drug will be dispensed in sachets (14 pills in each) once in 7 
days for 48 days. 
 
SUBJECT SELECTION: 
                As and when patients reporting at OPD of AyothidassPandithar Hospital 
with symptoms mentioned in inclusion criteria will be subjected to screening test & 
documentation will be done by using screening proforma. 
 
INCLUSION CRITERIA: 
1. Male infertile 
2. Age 21- 45 year 
3. Maritial status -  more than 1 year 
4. Sperm count   ≤ 40 million / ejaculation  
5. Motility less than ≤ 50 % 
6. Patients who are willing to sign the informed consent stating that he will 
continuously stick to the treatment during 48days but can opt out of the trial of 
his own conscious discretion. 
7. Patients who are willing   to give specimen of blood, urine and semen before 
and after treatment. 
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EXCLUSION CRITERIA 
 
1. Azoospermia 
2. Hydrocele 
3. Diabetes mellitus 
4. Hypertension 
5. Endocrine disorders[hypothyroidism&hyperthyroidism] 
6. Cardiac diseases 
7. VDRL & STD 
8. Inguinal Hernia 
9. Renal diseases 
10. Varicose veins 
 
WITHDRAWAL CRITERIA 
1. Intolerance to the drug & development of adverse reactions during drug trial. 
2. Poor patient compliance & defaulters. 
3. Patient turned unwilling to continue in the course of clinical trial. 
4. Increase in severity of symptoms. 
 
TEST & ASSESSMENTS 
 
A.CLINICAL ASSESSMENT - SIDDHA ASSESSMENT 
B. ROUTINE INVESTIGATION 
C. SPECIFIC INVESTIGATION 
 
A. CLINICAL ASSESSMENT (5 
 Premature ejaculation  
 Nocturnal emission 
 Erectile dysfunction 
 Painful coitus 
 Painful micturition 
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SIDDHA ASSESSMENT 
1.Thinai: 
 Kurinchi (hill areas) 
 Mullai (forest) 
 Marutham (fertile land) 
 Neidhal (coastal area) 
 Palai (desert) 
 
2. ParuvaKalam (season)  
 Karkaalam (Aug 18 – Oct 17) 
 Koothirkaalm (Oct 18 – Dec 16) 
 Munpanikaalm (Dec 17 – Feb 12) 
 Pinpanikaalam (Feb 13 – April 13) 
 Ilavenilkaalam (April 14 – June 14) 
 Muthuvenilkaalam (June 15 – Aug 17) 
 
3. Poripulankal: 
 Mei (Skin etc) 
 Vaai (Tongue etc) 
 Kan (Eye etc) 
 Mooku (Nose etc) 
 Sevi (Ear etc) 
 
4. Ennvagaithervu (Eight types of Examination): 
 Naadi 
 Sparisam 
 Naa 
 Niram 
 Mozhi 
 Vizhi 
 Malam 
 Moothiram 
o Neerkuri 
o Neikuri 
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B.  ROUTINE INVESTIGATION 
 Hb(gm/dl) 
 Total WBC Count(cells/cumm) 
 DC-  Polymorphs (%) 
 Lymphocytes (%)  
 Eosinophils (%) 
 Monocytes (%) 
 Basophils (%)  
 Total RBC count million cells/cumm) 
 ESR (Men 6-12mm/hr Women 7-18 mm/hr) 
 B. glucose (mg/dl) F & PP 
 
LIPID PROFILE 
 Serum T. cholesterol(mg/dl)- 
 HDL cholesterol(mg/dl)- 
 LDL cholesterol(mg/dl)- 
 VLDL cholesterol(mg/dl)- 
 Serum triglycerides (mg/dl)-   
 
 KIDNEY FUNCTION TEST 
 B. urea(mg/dl)  
 S. total creatinine (mg/dl) 
 
LIVER FUNCTION TEST 
 S. total bilirubin(mg/dl)  
 S. direct bilirubin (mg/dl) 
 S. indirect bilirubin (mg/dl) 
 SGOT(u/l) 
 SGPT (u/l) 
 S. alkaline phosphataseu/l)  
 S. total protein(g/dl)  
 S. albumin (g/dl) 
 S. globulin (g/dl) 
 S. calcium (mg/dl) 
 S. phosphorous (mg/dl) 
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URINE EXAMINATION  
 Albumin 
 Sugar (Fasting & post prandial) 
 Deposits  
 Bile salts  
 Bile pigments 
 Urobilinogen  
 
Semen analysis –   
 Volume 
 Colour  
 Appearance 
 Viscosity 
 Liquification time 
 Fructose 
 Sperm count 
 Motility 
 Morphology 
 
  STUDY ENROLLMENT: 
 In this clinical trial patients reporting at NIS OPD with the clinical symptoms 
of premature ejaculation, Nocturnal emission, Erectile dysfunction, Painful 
coitus, Painful micturition were  examined clinically for enrolling in the study 
based on the inclusion and exclusion criteria.  
 The patients in this study were informed (Form-V) about the objective of the 
study, trial drug, possible outcomes in their own language and terms 
understandable to them. 
 After ascertaining the patient’s willingness, informed consent wereobtained in 
writing from them in the consent form. (Form- VI) 
 All these patients were given unique registration card in which patient’s 
registration number of the study, Address, Phone number and Doctors phone 
number etc. so as to report easily and if any adverse reactions arise. 
 Complete clinical history, complaints and duration, examination findings-- all 
were recorded in the prescribed Proforma in the history and clinical 
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assessment forms separately. Screening Form- I were filled up; Form –II and 
Form –III were used for recording the patient’s history, clinical   examination 
of symptoms and signs and laboratory investigations respectively. 
 Patients were advised to take the trial drug and appropriate dietary advice 
(Form IV-D) was given according to the patients’ perfect understanding. 
 
CONDUCT OF THE STUDY: 
          The trial drug THATHU VIRUTHI KULIGAI(Internal) was given for 48 days.        
          Patients were advised to visit the hospital once in 12 days to get the trial drug.  
At each clinical visit clinical assessment will be done and prognosis was noted.  
          Laboratory investigations & SEMEN ANALYSIS was done on 0th day   & 48 
th day of the trial for OP patients.  
If any trial patient who fails to collect the trial drug on the prescribed day but 
wants to continue in the trial from the next day or two, he was allowed, but defaulters 
of one week and more were not be allowed to continue and be withdrawn from the 
study with fresh case being included.         
 
DATA MANAGEMENT 
After enrolling the patient in the study, a separate file for each patient were 
opened and all forms were filed in the file. Study No. and Patient No. will be entered 
on the top of file for easy identification. Whenever the study patient visits OPD 
during the study period, the respective patient file will be taken and necessary 
recordings will be made at the assessment form or other suitable forms. 
 
The screening forms were filed separately. The Data recordings will be 
monitored for completion by HOD and adverse event by Sr. Research Officer 
(Statistics). All forms were further scrutinized in presence of Investigators by Sr. 
Research Officer (Statistics) for logical errors and incompleteness of data to avoid any 
bias. No modification in the results is permitted for unbiased reports. 
 
STATISTICAL ANALYSIS: 
 
All collected data will be entered into the computer and manually cross-
checked the correctness of the data entry. The clinical symptoms and labarotary 
investigation of semen will be analyzed by comparing the two point of data (before 
and after treatment) paired test and chi-square test will be employed to study the 
efficacy of treatment. Further, the effect of co factors (age, occupation, socio 
economic status.etc) were be statistically analyzed.  
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OUTCOME 
1. PRIMARY OUT COME 
 Primary Outcome is mainly assessed by increase in the sperm count and 
motility % 
RESULT 
SPERM COUNT & 
MOTILITY 
(/ ejaculates) 
FROM TO 
GOOD 
SPERM COUNT * ≤ 40    million ≥ 60    million 
MOTILITY % #(RM+PM) ≤ 50% ≥   70 % 
MODERATE 
SPERM COUNT * ≤ 40    million > 50   million 
MOTILITY % #(RM+PM) ≤ 50% ≥ 60 % 
MILD 
SPERM COUNT * ≤ 40    million 40-50 million 
MOTILITY % #(RM+PM) ≤ 50% > 50 % 
 
NOTE: 
*  As per 1999 WHO criteria (1) standard value for total number of spermatozoa ≥ 40 
million per ejaculates. 
* As per 1999 WHO criteria (1) standard value for motility is ≥ 50 % million per 
ejaculates. 
  Progressive motility (PM) -  ≥ 50 % 
  Rapid motility (RM)  -  25 % 
 
2. SECONDARY OUT COME 
 Secondary Out Come is mainly assessed by reduce the clinical symptoms. 
 
ADVERSE EFFECT/SERIOUS EFFECT MANAGEMENT: 
 
If the trial patient develops any adverse reaction. It will be recorded in 
pharmacovigilence form, and he would be immediately referred to of 
Pharmacovigilance department of NIS and proper management will be given in OPD 
of National institute of siddha.  
 
ETHICAL ISSUES 
1. Informed consent were obtained from the patient after explaining about the 
clinical trial in the understandable language to the patient. 
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2. The data collected from the patient were kept confidentially. 
3. After getting the consent of the patient in the consent form they will be 
enrolled in the study 
4. Treatment would be provided free of cost.  
5. No other external or internal medicines were used. There will be no 
infringement on the rights of patient.    
6. To prevent any infection, while collecting blood sample from the patient, only 
disposable      syringes, disposable gloves, and needles were used under proper 
sterilization cover. 
7. The patients who were excluded (as per exclusion citeria) were given proper 
treatment at National Institute of Siddha 
8. In conditions of treatment failure, adverse reactions, patients were given 
alternative treatment at the National Institute of Siddha with full care 
throughout the end of the treatment 
 
ASSESSMENT FORMS 
FORM I  SCREENING AND SELECTION PROFORMA 
FORM II  CLINICAL RESEARCH FORM 
FORM lll LABORATORY INVESTIGATION ON ENROLLMENT AND  
  CONCLUSION OF TRIAL 
FORM IV  DRUG COMPLIANCE FORM  
FORM V  PATIENT INFORMATION SHEET  
FORM VI      PATIENT CONSENT FORM 
FORM VII WITHDRAWAL FORM / ADVERSE REACTION FORM /     
PHARMACOVIGILENCE FORM 
FORM VIII    DIETARY ADVICE FORM 
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STANDARD OPERATING PROCEDURE OF THE TRIAL DRUG  
THATHU VIRUTHI KULIGAI 
 
SOURCE OF RAW DRUGS:  
 
           The required raw drugs for the preparation ofThadhuviruthikuligai was 
purchased from a well reputed country shop. The raw drugs were authenticated by the 
Asst.Prof of medicinal botany at NIS. Then the raw drugs were purified as mentioned 
in siddha literature. The medicine was prepared in Gunapadam lab of National 
Institute of Siddha. 
 
REQUIRED RAW DRUGS: 
 
1.Poonaikalivithai (Mucunapruriens, Linn Dc) 
2. Thanneervittankizhangu (Asparagus racemosus, Wild) 
3. Nelapanaikilangu (Curculigoorchiodes, Linn) 
4. Neermulivithai (Hygrophyllaauriculata, Linn) 
5. Karuvellampisin (Acacia Arbica Wild) 
6. Sevellaneer (Coccus nucifera, Linn) 
7. Lemonjuice (Citruslemon)   
 
METHOD OF PURIFICATION:  
THADHU VIRUTHI KULIGAI(Internal) 
1. Poonaikalivithai (Mucunapruiens, Linn Dc) 
a. Part used: Seed 
b.  Fry the seeds in a mud vessel. 
2.  Thaneervittan (Asparagus racemosus, Wild.) 
       a.  Part used: Root tuber 
        b. Wash the  root tuber with running water and dry it. 
 
3. Nilapanaikilangu (Curculigoorchinoides, Linn) 
a. Part used: Root tuber 
b. Wash the root tuber with running water and dry it. 
 
4. Neermullividhai (Hygrophyllaauriculata, Linn) 
a. Part used: Seed 
b. Fry the seeds in a mud vessel. 
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5. Karuvellampisin (Acacia arabica wild) 
a. Part used: Gum & Flower  
b. Dry all the above in shade and powder it. 
 
PREPARATION: 
All these five ingridients were soaked in Lime Fruit Juice for a day, then 
rubbed in a kalvam with the same lime juice for 2or3days then allowed to dry, again 
rubbed with Red illaneer for another 2or 3days and till it is waxy consistency. It was 
rounded in to pills of 5 grains or about the size of illanthaivirai[325mg] and dried in 
shade. 
 
DRUG STORAGE:  
The trial drug ―THATHU VIRUTHI KULIGAI‖ (internal)  
was stored in clean and dry wide mouthed glass bottles. 
 
DISPENSING:   
The prepared drug were dispensed in sachets (14 pills in each) once in 7 days 
for 45 days. 
 
POONAIKALI 
Botanical name :  Mucunapruriens 
Family  :  Fabaceae 
 
Plant description: 
 
Twining herbs, branches terete, striate, downy pubescent. Leaves trifoliate, 
leaves ovate-rhomboid, apprised white-pubescent. Flowers dark purple with yellow 
shade on the petal in long axillary racemes. Pods curved, prominently s- shape, 
densely silk pubescent with persistent pale brown or gray irritant bristles, seeds 4-6, 
orbicular. 
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Geographical distribution:   
 
World          :  Cultivated in Tropics 
India         :    occasionally in damp places, bushes, hedges and ravines  
   throughout India. 
Vernacular names   :  Sanskrit: Atmagupta, hindi: kivach, kan: Turachi- gida, telgu:                           
Dulagondi, Tamil    :   Poonai kali. 
Trade name         :  Common cowitch 
 Taste - Astringent. 
 Potency - Moderate. 
 Division - Sweet. 
 Part used- Seed. 
 Action- Nervine tonic, Aphordisiac 
 
Medicinal uses:  
 Traditionally in India the seeds of   Mucunapruriens are used as a tonic 
and aphrodisiac for male virility. 
 Seeds are highly reputed medicine for curing Parkinson’s disease. 
 It is used in fracture healing. 
 It is used as anti depressant drug. 
 The pods are anthelmintic 
 The seeds are anti- inflammatory 
 The hairs are used as vermifuge 
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THANNEER VITTAN 
Botanical name :   Asparagus racemosusWilld. 
Family  :   Liliaceace 
 
Plant description:  
 
Perennial armed climbing shrub. Roots tuberous. Stem angular. Leaves scaly. 
cladodes 2-6 in whorl, linear, falcate. Flowers white in racemes. Fruit berry, globose, 
red when ripe 3-6 seeded. 
 
Geographical distribution: 
World   : south Asia, China, Malaysia, and Australia. 
India    : occasional in forests all over India. 
 
Names: sana: satavariGuj: Ekalakanto, Shatavari; Hind: Chatwal, kan: 
Aheruballi, mal: Shatavalli, Mar: Zatar, Tamil: Kilvari, Catavari; tel: 
Pilligadallu. 
 
Trade name: Wild Asparagus. 
 
 Taste -Sweet. 
 Potency - Moderate. 
 Division - Sweet. 
 Part used- leaves. 
               Action- Aphrodisiac, Nutritive, Antispasmodic. 
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Medicinal uses:  
 The root is used in indigenous medicine. 
 It is considered aphrodisiac and demulcent. 
 It is prescribed for increasing the secretion of milk 
 The root is used to cure tuberculosis, leprosy, skin diseases, inflammations 
 
NILAPPANAI KIZHANGU 
 
Botanical name   : Curculigoorchides, Linn 
Family  : Hypoxidaceae 
 
Plant description:  
 
It is an herbaceous tuberous perennial with a short or elongate root stock 
bearing several fleshy lateral roots: Leaves are sessile or petiolate. 
 
Geographical distribution: 
World :   Mountain grassland, majority from Taiwan. 
India :   Forests throughout India. 
Names :    san: Talamuli, hin: kali mooslie, Bengali: talmalu 
 
Trade name: Golden eye grass, Black musli. 
 Taste     -      Sweet   
 Potency -      Moderate 
 Class    -       sweet 
 Action -       Aphrodisiac 
 
Medicinal uses:  
 It is Rejuventating and aphrodisiac herb. 
 It is a sexual tonic. 
 It increases Lipido and physical strength in men. 
 It promotes sperm count. It stimulates male sex hormone. 
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NEERMULLI 
 
Botanical name :   Hygrophilaauriculata,Linn 
Family   :   Acanthaceae 
 
Plant description:  
  
 It is an herb growing in wet places. A stout herb. Stems fasiculate, 
subquadrangular, erect,0.6-1.5 m tall, thickened at the nods, hispid with longhairswith 
axillary spines, Leaves hairy, oblanceolate, in whorls, Flowers purple blue, bilabilate, 
Fruits capsule. 
 
Geographical distribution: 
            India  :  Forests throughout India due to its exploitation. 
            Names  :  Hygrophila, Temple plant, Marsh barbell, Gokanta. 
           Trade name :  Marshbarble 
            Taste  :  Sweet 
Potencey :  Moderate 
            Class  :  Sweet 
          Action  :  Aphrodisiac 
 
Medicinal uses:  
 
It stimulates the male genital system and is beneficial in the treatment ofsexual 
debility, premature ejaculation and erectile failure. 
The roots and leaves have diuretic properties. It helps in treating urinary 
cystitis and calculi. The seeds are useful in increasing Libido. 
 
61 
 
KARUVEL 
 
Botanical name :  Acacia arabica 
Family  :  Mimosaceae 
 
Plant description: 
  
 It is a small thorny decididous tree. It can grow upto 20 meters tall. The green 
grey leaves are alternate and bipinnate. The flowers are yellow cream coloured and 
grow on spikes just above the thorns.  
 
Geographical distribution: 
 
World  :   It is native to semi-desert regions of sub-sharan Africa, as well    
                 as oman, Pakistan. 
India  :  Throughout west costal India. 
 Names :   Gum acacia, Gum Arabict tree, sudan gum and sudan gum  
      Arabic. 
Trade name :   Gum acacia. 
Taste  :  Astringent  
potency  :  modrate 
class   :  sweet. 
Action  :  Aphrodisiac. 
 
Medicinal uses:   
 
 Gum arabica is used to provide a soothing coating over inflammations in the 
respiratory, alimentary, and urinary tracts. 
ILANEER 
Botanical name : Cocus nucifera 
Family  :  Arecacea 
Plant description :  It is a tree. The term coconut can refer to the whole plant or 
      the  seed, or the fruit, which is drupe, not a nut. The coconut 
      tree is topped by a crown composed of about 25-30 pinnate 
      feather-like leaves that are bot 6 feet wide and 18 feet long. 
     There are about 200 leafletsin every leaf colored yellow green 
        while mature turns to brown. 
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Geographical distribution: 
World  :  India –Indonesia region. 
India  :  throughout India. 
Names  :  Kalpavriksha, Pokokseibuguna, Buko tree. 
 Trade name :  coconut tree 
Taste  :  Sweet, Astringent, 
Potency  : moderate,  
class   :  sweet. 
Action  :  Nutritive, demulcent. 
 
Medicinal uses: 
 While consuming the flesh of coconut with coconut milk and honey it 
increases libido in both men and women. 
 It is valued in traditional medicine for the many health benefits it provides, 
from graying hair to cancer. 
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RAW DRUGS  
MUCUNA PRURIENS 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
ASPARAGUS RACEMOSUS 
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HYGROPHILA AURICULATA 
 
 
 
 
CURCULIGO ORCIOIDES 
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ACACIA ARABICA 
 
 
 
 
 
 
 
 
 
 
 
ACACIA ARABICA FLOWER 
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PHYSIOCHEMICAL ANALYSIS OF –THATHUVIUTHI KULIGAI 
 
1. Loss on Drying: 
An accurately weighed 2g of ThathuviuthiKuligaiformulation was taken in a 
tarred glass bottle. The crude drug was heated at 105
0
C for 6 hours in an oven till a 
constant weight. Percentage moisture content of the sample was calculated with 
reference to the shade dried material. 
 
2. Determination of total ash: 
Weighed accurately 2g of ThathuviuthiKuligaiformulation was added in 
crucible at a temperature 600
0
C in a muffle furnace till carbon free ash was obtained. 
It was calculated with reference to the air-dried drug.  
 
3. Determination of acid insoluble ash: 
Ash above obtained, was boiled for 5min with 25ml of 1M Hydrochloric acid 
and filtered using an ash less filter paper. Insoluble matter retained on filter paper was 
washed with hot water and filter paper was burnt to a constant weight in a muffler 
furnace. The percentage of acid insoluble as was calculated with reference to the air-
dried drug. 
 
4. Determination of water soluble ash: 
Total ash 1g was boiled for 5min with 25ml water and insoluble matter collected 
on an ash less filter paper was washed with hot water and ignited for 15 min at a 
temperature not exceeding 450
0
C in a muffle furnace. The amount of soluble ash is 
determined by drying the filtrate.  
 
5. Determination of water soluble Extractive: 
5gm of air dried drug, coarsely powered Thathuviuthi Kuligai was macerated 
with 100ml of distilled water in a closed flask for twenty-four hours shaking 
frequently. Solution was filtered and 25 ml of filtrated was evaporated in a tarred flat 
bottom shallow dish, further dried at 100
0
 C and weighted. The percentage of water 
soluble extractive was calculated with reference to the air-dried drugs.   
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6. Determination of alcohol soluble extractive: 
2.5gm. of air dried drugs, coarsely powdered Thathuviuthi Kuligai was 
macerated with 50 ml. alcohol in closed flask for 24 hrs. With frequent shaking it was 
filtered rapidly taking precaution against loss of alcohol. 10ml of filtrate was then 
evaporated in a tarred flat bottom shallow dish, dried at 100
0
C and weighted. The 
percentage of alcohol soluble extractive was calculated with reference to air dried 
drug. 
 
S.No Parameters Percentage 
1 Loss on drying 4.18% 
2 Total ash value 4.93% 
3 Acid insoluble ash 1.01% 
4 Water soluble ash 1.04% 
5 Water soluble extraction 36.29% 
6 Alcohol soluble extraction 8.52% 
 
The above stated physiochemical properties for the given sample certified to 
be present. 
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PRELIMINARY PHYTOCHEMICAL SCREENING 
 
THATHUVIRUTHI KULIGAI 
The preliminary phytochemical screening test was carried out for each extract 
of  Thathuviruthi Kuligai as per the standard procedure. 
 
1. Detection of alkaloids: 
 Extracts were dissolved individually in dilute Hydrochloric acid and filtered. 
 
a) Mayer’s Test: Filtrates were treated with Mayer’s reagent (Potassium Mercuric 
Iodide). Formation of a yellow colored precipitate indicates the presence of alkaloids.  
 
b) Wagner’s Test: Filtrates were treated with Wagner’s reagent (Iodine in Potassium 
Iodide). Formation of brown/reddish precipitate indicates the presence of alkaloids.  
 
c) Dragendroff’s Test: Filtrates were treated with Dragendroff’s reagent (solution of 
Potassium Bismuth Iodide). Formation of red precipitate indicates the presence of 
alkaloids. 
 
d) Hager’s Test: Filtrates were treated with Hager’s reagent (saturated picric acid 
solution). Presence of alkaloids confirmed by the formation of yellow colored 
precipitate.  
 
2. Detection of carbohydrates: 
Extracts were dissolved individually in 5 ml distilled water and filtered. The 
filtrates were used to test for the presence of carbohydrates. 
 
a) Molisch’s Test:  
To 2 ml of plant sample extract, two drops of alcoholic solution of α- naphthol 
are added. The mixture is shaken well and few drops of concentrated sulphuric acid is 
added slowly along the sides of test tube. A violet ring indicates the presence of 
carbohydrates.   
 
b) Benedict’s Test: 
Filtrates were treated with Benedict’s reagent and heated gently. Orange red 
precipitate indicates the presence of reducing sugars. 
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3. Detection of glycosides: 
Extracts were hydrolyzed with dil. HCl, and then subjected to test for glycosides.  
 
a) Modified Borntrager’s Test: Extracts were treated with Ferric Chloride solution 
and immersed in boiling water for about 5 minutes. The mixture was cooled and 
extracted with equal volumes of benzene. The benzene layer was separated and 
treated with ammonia solution. Formation of rose-pink color in the ammonical layer 
indicates the presence of anthranol glycosides.  
 
b) Cardiac glycoside (Keller-Killiani test):  Extract was shaken with distilled water 
(5 mL). To this, glacial acetic acid (2 mL) containing a few drops of ferric chloride 
was added, followed byH2SO4 (1 mL) along the side of the test tube. The formation 
of brown ring at the interface gives positive indication for cardiac glycoside and a 
violet ring may appear below the brown ring 
 
4. Detection of saponins 
a) Froth Test: Extracts were diluted with distilled water to 20ml and this was shaken 
in a graduated cylinder for 15 minutes. Formation of 1 cm layer of foam indicates the 
presence of saponins.  
 
b) Foam Test: 0.5 gm of extract was shaken with 2 ml of water. If foam produced 
persists for ten minutes it indicates the presence of saponins.  
 
5. Detection of phytosterols  
 
a) Salkowski’s Test: Extracts were treated with chloroform and filtered. The filtrates 
were treated with few drops of Conc. Sulphuric acid, shaken and allowed to stand. 
Appearance of golden yellow color indicates the presence of triterpenes. 
 
6. Detection of phenols Ferric Chloride Test: 
Extracts were treated with 3-4 drops of ferric chloride solution. Formation of 
bluish black color indicates the presence of phenols.  
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7. Detection of tannins Gelatin Test: 
The extract is dissolved in 5 ml of distilled water and 2 ml of 1% solution of 
Gelatin containing 10% NaCl is added to it. White precipitate indicates the presence 
of phenolic compounds.  
 
8. Detection of Flavonoids  
 
a) Alkaline Reagent Test: Extracts were treated with few drops of sodium hydroxide 
solution. Formation of intense yellow color, which becomes colorless on addition of 
dilute acid, indicates the presence of flavonoids. 
 
 b) Lead acetate Test: Extracts were treated with few drops of lead acetate solution. 
Formation of yellow color precipitate indicates the presence of flavonoids.  
 
9. Detection of proteins and aminoacids 
 
a) Xanthoproteic Test: The extracts were treated with few drops of conc. Nitric acid. 
Formation of yellow color indicates the presence of proteins. 
 
b) Ninhydrin Test: To the extract, 0.25% w/v ninhydrin reagent was added and 
boiled for few minutes. Formation of blue color indicates the presence of amino acid. 
 
10.Detection of diterpenes  
Copper Acetate Test: 
 
 Extracts were dissolved in water and treated with 3-4 drops of copper acetate 
solution. Formation of emerald green color indicates the presence of diterpenes   
 
11. Gum and Mucilage:  
 
To 1ml of extract add 2.5ml of absolute alcohol and stirring constantly. Then 
the precipitate was dried in air and examine for its swelling properties. Swelling was 
observed that will indicate presence of gum and mucilage. 
 
12. Test for Fixed oils and Fats  
a. Spot test  :A small quantity of extract is pressed between two filter papers. Oil 
stain on the paper indicates the presence of fixed oils.  
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13. Test for Quinones 
Extract was treated with sodium hydroxide blue or red precipitate indicates the 
presence of Quinones. 
The Preliminary phytochemical studies of aqueous extract of 
ThathuviruthiKuligaiwere done using standard procedures. The results were 
presented in tables. The present study reveals that the bioactive compounds were 
present in all the extracts of ThathuviruthiKuligai. 
S.No Phytochemicals Test Name H2O Extract 
1.  Alkaloids 
Mayer’s Test +ve 
Wagner’s Test +ve 
Dragendroff’s Test +ve 
Hager’s Test +ve 
2.  Carbohydrates 
Molisch’s Test: +ve 
Benedict’s Test +ve 
3.  Glycoside 
Modified Borntrager’s 
Test 
-ve 
Keller Killiani -ve 
4.  Saponin  
Froth Test +ve 
Foam Test +ve 
5.  Phytosterol Salkowski’s Test -ve 
6.  Phenols Ferric Chloride Test +ve 
7.  Tannins Gelatin Test -ve 
8.  Flavonoids  
Alkaline Reagent Test +ve 
Lead acetate Test -ve 
9.  
Proteins and amino 
acids 
Xanthoproteic Test +ve 
10.  Diterpenes Copper Acetate Test +ve 
11.  Gum & Mucilage Extract + Alcohol +ve 
12.  Fat & Fixed Oil Spot Test -ve 
13.  Quinones NAOH + Extract +ve 
 
+ve/-ve present or absent if component tested 
The above stated physiochemical properties for the given sample certified to be 
present. 
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BIO -CHEMICAL ANALYSIS OF THATHU VIRUTHI KULIKAI                
ANALYSED AT NATIONAL INSTITUTE OF SIDDHA 
 
S. 
No 
EXPERIMENT OBSERVATION INFERENCE 
1.         Appearance of sample Dark brown in 
colour 
 
2. Solubility: 
a. A little(500mg) of the sample is 
shaken well with distilled water. 
b. A little(500mg) of the sample is 
shaken well with con. HCl/Con. 
H2So4 
Sparingly soluble 
 
 
presence of silicate 
3. Action of Heat: 
   A small amount(500mg) of the 
sample is taken in a dry test tube 
and heated gently at first and then 
strong. 
 
White fumes   
evolved 
 
presence of 
Carbonate 
 
4. Flame Test: 
  A small amount(500mg) of the 
sample is made into a paste with 
con. HCl in a watch glass and 
introduced into non-luminous part 
of the Bunsen flame. 
No Bluish green 
flame appeared. 
Absence of Copper 
5. Ash Test: s A filter paper is 
soaked into a mixture of sample 
and dil. cobalt nitrate solution and 
introduced into the Bunsen flame 
and ignited 
Appearance of 
Yellow colour 
flame 
Absence of Sodium 
 
Preparation of Extract:  5gm ofThathuviruthikuligai is weighed accurately and 
placed in a 250ml clean beaker and added with 50ml of distilled water. Then it is 
boiled well for about 10 minutes. Then it is cooled and filtered in a 100ml volumetric 
flask and made up to 100ml with distilled water. This preparation is used for the 
qualitative analysis of acidic/basic radicals and biochemical elements in it. 
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S. 
No 
EXPERIMENT OBSERVATION INFERENCE 
 I.Test for Acid Radicals   
1. 
Test for Sulphate: a.2ml of the above 
prepared extract is taken in a test tube 
to this added 2ml of 4% dil ammonium 
oxalate solution 
No Cloudy 
appearance 
Absence of 
Sulphate 
2. 
Test for Chloride: 2ml of the above 
prepared extracts is added with 2ml of 
dil-HCl is added until the 
effervescence ceases off. 
cloudy 
appearance 
present 
Presence 
of Chloride 
3. 
Test for Phosphate: 2ml of the 
extract is treated with 2ml of dil. 
ammonium molybdate solution and 
2ml of con. HNo3 
Yellow 
appearance was 
formed 
Presence 
of Phosphate 
4. 
Test for Carbonate: 2ml of the 
extract is treated with 2mldil. 
magnesium sulphate solution 
 
Cloudy 
appearance was 
evolved 
Presence 
of carbonate 
5. 
Test for Nitrate: 1gm of the 
substance is heated with copper 
turning and concentrated H2So4 and 
viewed the test tube vertically down. 
 
No Brown gas is 
evolved 
 
Absence 
of Nitrate 
6. 
Test for Sulphide: 1gm of the 
substance is treated with 2ml of con. 
HCL 
No Rotten Egg 
Smelling gas 
evolved 
absent 
of Sulphide 
7. 
Test for Fluoride & Oxalate: 2ml of 
extract is added with 2ml of dil. Acetic 
acid and 2ml dil. calcium chloride 
solution and heated. 
Presence Cloudy         
appearance 
Presence 
of fluoride and 
oxalate 
8. 
Test for Nitrite: 3drops of the extract 
is placed on a filter paper, on that-2 
drops of dil. acetic acid and 2 drops of 
dil. Benzidine solution is placed. 
No Characteristic 
changes 
Absence 
of Nitrite 
9. 
Test for Borate:2 Pinches(50mg) of 
the substance is made into paste by 
using dil. sulphuric acid and alcohol 
(95%) and introduced into the blue 
flame. 
No appearance of 
Bluish green 
colour 
Absence 
of borate 
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 II. Test for Basic Radicals   
1. 
Test for Lead: 
2ml of the extract is added with 2ml of 
dil. potassium iodine solution. 
NoYellow 
Precipitate is 
obtained. 
Absence of 
Lead 
2. 
Test for Copper: One pinch(50mg) of 
substance is made into paste with con. 
HClin a watch glass and introduced 
into the non-. luminuous part of the 
flame 
No Blue colour 
apeared 
 
Absence 
of copper 
 
 
3. 
Test for Aluminium: To the 2ml of 
extract dil. sodium hydroxide is added 
in 5 drops to excess. 
No Yellow 
colour appeared 
Absence 
of aluminium 
4. 
Test for Iron: a. To the 2ml of extract 
add 2ml of dil. ammonium solution 
b. To the 2ml of extract 2ml 
thiocyanate solution and 2ml of con 
HNo3 is added 
 
No red colour 
appears 
 
 
absence 
of Iron 
 
5. 
Test for Zinc: To 2ml of the extract 
dil. sodium hydroxide solution is added 
in 5 drops to excess and dil. 
ammonium chloride is added. 
 
White 
precipitate is   
was formed 
Presence 
of Zinc 
6. 
Test for Calcium: 2ml of the extract is 
added with 2ml of 4% dil. ammonium 
oxalate solution 
Cloudy 
appearance and 
white precipitate 
was formed 
 
Presence 
of Calcium 
7. 
Test for Magnesium: To 2ml of 
extract dil. sodium hydroxide solution 
is added in drops toexcess. 
No White 
precipitate is 
obtained 
Presence 
of Magnesium 
8. 
Test for Ammonium: To 2ml of 
extract 1 ml of Nessler's reagent and 
excess of dil. sodium hydroxide 
solution are added. 
 
No Brown 
colour appeared 
 
absence 
of ammonium 
9. 
Test for Potassium: A pinch(25mg) of 
substance is treated of with 2ml of dil. 
sodium nitrite solution and then treated 
with 2ml of dil. cobalt nitrate in 30% 
dil. glacial acetic acid. 
 
No Yellowish 
precipitate is 
obtained. 
absence 
of Potassium 
10. 
Test for Sodium: 
2 pinches(50mg) of the substance is 
made into paste by using HCl and 
introduced into the blue flame of 
Bunsen burner. 
No yellow 
colour flame 
appeared 
Absence 
of sodium 
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11. 
Test for Mercury: 
2ml of the extract is treated with 2ml 
of dil. sodium hydroxide solution. 
No yellow 
precipitate is 
obtained 
Absence 
of mercury 
12. 
Test for Arsenic: 
2ml of the extract is treated with 2ml 
of dil. sodium hydroxide solution. 
 
No brownish red 
precipitate is 
obtained 
 
Absence 
of arsenic 
 III. Miscellaneous   
1. 
Test for Starch: 
2ml of extract is treated with weak dil. 
iodine solution 
 
blue colour 
developed 
 
presence 
of starch 
2. 
Test for Reducing Sugar: 5ml of 
Benedict's qualitative solution is taken 
in a test tube and allowed to boil for 2 
minutes and added 8 to 10 drops of the 
extract and again boil it for 2 minutes. 
The colour changes are noted. 
Green colour 
developed 
 
Prsence of 
Reducing sugar 
3. 
Test for The Alkaloids: 
a) 2ml of the extract is treated with 
2ml of dil. potassium lodide solution. 
b)  2ml of the extract is treated with 
2ml of dil. picric acid. 
c)  2ml of the extract is treated with 
2ml of dil. phosphotungstic acid. 
No Yellow colour 
developed 
Presence 
of Alkaloid 
4. 
Test for Tannic Acid: 
2ml of extract is treated with 2ml of 
dil. ferric chloride solution 
No black precipitate 
is obtained 
Absence 
of Tannic acid 
5. 
Test for Unsaturated Compound: 
To the 2ml of extract 2ml of dil. 
Potassium permanganate solution is 
added. 
Potassium 
permanganate was 
not decolourised 
Absence 
of unsaturated 
compound 
6. 
Test for Amino Acid: 
2 drops of the extract is placed on a 
filter paper and dried well. 20ml of 
Biurette reagent is added. 
violet colour 
developed 
Presence 
of Amino acids 
7. 
Test for Type of Compound: 
2ml of the extract is treated with 2 ml 
of dil. ferric chloride solution. 
No green colour 
developed 
No red colour 
developedNo violet 
colour developed 
No blue colour 
developed 
Absence 
ooxyquinolepine
phrine and pyro 
catechol 
Antipyrine, 
Aliphatic amino 
acidsandmeconic 
acid are absent 
Apomorphine 
salicylate and 
Resorcinol 
areabsent. 
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In biochemical analysis the trial drug contains very good antioxidant and 
aphrodisiac activity. So, the drug is proved that no adverse reaction was reported 
during the treatment period in all 40 cases. Therefore, I conclude that the trial drug is 
safe in male infertility cases. 
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OBSERVATION AND RESULTS 
1.  AGE DISTRIBUTION 
 
Age (yrs) Cases 
No Percentage (%) 
20- 25 2 5 
25-30 6 15 
30-35 25 62.5 
35-40 6 15 
40-45 1 2.5 
 
 
Fig. 1 
 
 
OBSERVATION: 
Among 40 cases 2(5%) cases are between the age group of 20-25yrs,15% 
cases are between the age group of 25-20 yrs,62.5% cases are between the age group 
of 31-35 yrs,15% cases are between the age group of 36-40 yrs, 2.5%cases are 
between the age group of 41 -45yrs 
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79 
 
2) OCCUPATIONAL STATUS 
Sl. No Nature of Work No. of Cases Percentage 
1 Driver 6 12.5% 
2 IT professional 12 45% 
3 Electrician 4 10% 
4 Businessman 7 17.5% 
5 Coolie 5 12.5% 
6 Jobless 4 10% 
7 Associate professor 2 5% 
TOTAL 40 100% 
 
Fig.2 
 
OBSERVATION: 
Out of 40 patients 45% patients were working in hot atmosphere.IT Profession 
12Patients (30%), businessman7patients [17.5] Drivers (15. 0%).working in hot 
atmosphere. This plays a vital role in male infertility. This may be one of the causes 
for infertility. 
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3.  DIET HABITS: 
 
S.NO DIET HABITS NUMBER OF 
THE CASES 
PERCENTAGE 
1 Vegetarian 6 15% 
2 Non-vegetarian 34 85% 
Total  40 100% 
 
Fig.3 
 
 
OBSERVATION: 
Out of 40 patients 34(85%) were non-vegetarian and 6(15%) were vegetarian. 
This dietary style is more prone for developing infertility 
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4. PERSONAL HABITS 
 
Personal habits 
(smoking/alcohol/tobacco chewing) 
 
Case numbers 
 
 
percentage 
 
Smoking with alcohol 15 37.5% 
Smoking 10 25% 
Tobacco chewers 0 0% 
None of the above habits 15 37.5% 
Total 40 100% 
 
Fig .4 
 
OBSERVATION: 
 Out of 40 patients 15[37.5%] patients were with None of the above 
habits,15[37.5%] patients were with smokers ans social drinkers,10[25%] patients 
were with only smokers.Smoking,alcohol and secondary life style is the major cause 
of male infertility because it increases the concentration of free radicals in the seminal 
fluid. 
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5.MARITAL STATUS 
MARITAL STATUS NO OF CASES PERCENTAGE (%) 
Married 36 90% 
Unmarried 4 10% 
Total 40 100% 
 
Fig.5 
 
OBSERVATION 
Among 40 cases, 
 36(90%) cases were married 4 cases 
 (10%) were un married 
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6. SOCIO - ECONOMIC STATUS 
SOCIO -ECONOMIC 
STATUS 
NO OF CASES PERCENTAGE (%) 
Upper class 21 52.5% 
Middle class 10 25% 
Lower class 9 22.5% 
Total 40 100% 
 
Fig-6 
 
 
OBSERVATION: 
Out of 40 cases 
 Upper class group       - 21 cases (52.5%) 
 Middle class group     - 10 cases (25%) 
 Lower class group      - 9 caese (22.5%) 
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7. DURATION OF MALE INFERTILITY 
Duration (years) Cases 
Numbers Percentage (%) 
0 – 3 20 50% 
4 -6 10 25% 
7- 9 8 20% 
More than   10 2 5% 
Total 40 100% 
 
Fig-7: 
 
OBSERVATION: 
 50% of patients were within 0-3 years duration of infertility. 
 25% of patients were within 4years to 6 years of infertility. 
 20% of patients were within7yeara to 9years of infertility. 
 5% of patients were more than 10 years of infertility 
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8.THINAI 
 
 
 
 
 
 
 
 
 
Fig-8 
 
OBSERVATION 
 
12.5 %  of patients came from Marutham thinai 
7.5% of patients from Mullai thinai.  
77.5% of patients from Neithal thinai 
2.5% of patients from Kurunji thinai.  
 
0.00% 10.00% 20.00% 30.00% 40.00% 50.00% 60.00% 70.00% 80.00%
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0%
THINAI
Thinai 
 
cases 
No Percentage (%) 
Kurunji 1 2.5% 
Mullai 3 7.5% 
Marutham 5 12.5% 
Neithal 31 77.50% 
Palai 0 0 
Total 40 100 
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9. PARUVAKALAM 
Paruvakalam Cases 
No Percentage (%) 
Karkalam 0 0 
Koothirkalam 0 0 
Munpanikalam 0 0 
Pinpanikalam 40 100%% 
Elavenilkalam 0 0 
Muthuvenilkalam 0 0 
Total 40 100 
 
Fig-9: 
 
OBSERVATION: 
100% of the patients came in pinpanikalam. The body which is already been 
weak due to the effect of previous season.. 
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10. THEGI 
Type of Theygi No of cases Percentage 
Vatha thegi 12 30% 
Pitha thegi 18 45% 
Kaba thegi 10 25% 
Total 40 100% 
Fig – 10  
 
 
OBSERVATION: 
 30% of patients presenting with Vatha Thegi. 
 45% of patients presenting with Pitha Thegi. 
 25% of patients presenting with Kaba Thegi. 
 Pitha thegi are more prone to male infertility 
 
 
 
 
 
 
88 
 
11.THREE HUMORS 
Type of Humor No of cases Perceentage 
Vatham Abannan affected in 24 60 
Samanan affected in 20 50 
Pitham Sathagam affected in 40 100 
Kabam -Tharpagam affected in 26 65 
Fig -11 
 
OBSERVATION: 
 In Vatham 60% of patients (abannan) was affected due to pre-mature 
ejaculation, nocturnal ejaculation, burning micturition. 
 In Pitham 100%of patients (Sathagam pitham) was affected due to 
decreased sperm count, decreased sperm motility. 
 In Kabam 65% of patients (Tharpakam) was affected due to burning 
sensation of eyes. 
 In Saamanan 20% of patients was affected. 
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12.KOSAM (Five sheaths) 
Type of Kosam No of cases Percentage 
Annamaya Kosam 24 60% 
Pranamaya Kosam 0 0 
Manomaya Kosam 28 70% 
Vingnanamaya Kosam 0 0 
Anandhamaya Kosam 40 100 
Figt-12: 
 
OBSERVATION: 
 In 100%of the patients Annamayakosam was affected. (Two of the physical 
constituents saaram and senner affected). 
 70% of the patients ManomayaKosam was affected. (depression, Insomnia). 
 100%of the patients AnandhamayaKosam was affected. (decreased sperm count 
and motility). 
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13. UDAL THATHUGAL 
Udal Thathugal 
Cases 
No Percentage (%) 
Saaram 40 100 
Senneer 40 100 
Oon 0 0 
Kozhuppu 0 0 
Enbu 0 0 
Moolai 0 0 
Sukkilam 40 100 
Fig. 13 
 
OBSERVATION: 
 Saram was affected in 100% patients. 
 Senneer was affected in 100% patients. 
 Sukkilam was affected in 100% patients 
 Derangement of Saaram, Senneer, sukkilam or any one of this lead to 
development of infertility. 
100%
100%
100%
0% 20% 40% 60% 80% 100% 120%
saram
senneer
oon 
Kozhuppu
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Moolai
sukkilam
UDAL THATHUGAL
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14.ENVAGAI THERVUGAL 
 
Envagai Thervugal 
Cases 
No Percentage (%) 
Naa 5 12.5% 
Niram 0 0 
Sparisam 
a. Veppam 
b. Mithaveppam 
 
11 
29 
 
27.5% 
72.5% 
Mozhi 0 0 
Vizhi 0 0 
Malam 0 0 
Moothiram 7 17.5% 
Naadi 
a. Vathapitham 
b. Pithavatham 
 
13 
27 
 
32.5% 
67.5% 
Fig 14 
 
OBSERVATION: 
 Naa -12.5% of patients presenting with Dryness of tongue. 
 Sparisam – Sparisam was Veppam in 27.5%patients due to working in hot 
atmosphere. 
o Sparism was Methavepam in 72.5%patients. 
 Moothiram was affected in 17.5% patients (burning micturition). 
 Naadi -32.5% of the patients were presenting with Vatha Pitham Naadi. 
o 67.5% of the patients were presenting with Pitha Vatham Naadi. 
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15.BUONANCY OF WATER 
Buoyancy on water No       cases 
Percentage (%) 
 
Floating on Water 4 10% 
Not floating on Water 36 90% 
Total 40 100 
 
Fig. 15 
 
 
OBSERVATION: 
Buoyancy on water: 
 The important Siddha parameter to evaluate the Sperm.In 10% of the patient’s 
sperm were floating on water indicating abnormal condition. 90% of the 
patients presented sperms not were floating on water indicating normal 
condition. 
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16.NEERKURI 
Neerkuri 
Cases 
No Percentage 
Pale yellow 14 35% 
Yellow 4 10 
Dark yellow 3 7.5% 
Straw 19 47.5% 
Total 40 100 
 
Fig-16: 
 
 
OBSERVATION: 
 35% of patients the colour of the urine was pale yellow colour. 
 10% of the patients the colour of the urine was yellow colour. 
 7.5% of the patients the colour of the urine was dark yellow in colour. 
 47.5% of the patients the colour of the urine was straw coloured urine 
35%
10%
7%
48%
NEERKURI
pale yellow
yellow
dark yellow
straw
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17.  NEIKURI 
Neeikuri Cases 
Numbers Percentage 
Slowly spread 6 15% 
Fastly spread 30 75 
No spread 4 10% 
Total 40 100% 
Fig. 17 
 
 
OBSERVATION: 
 An important Siddha parameter reflecting the signs of Prognosis is   spreading 
pattern of the in the urine. 
 15% of patients the Neikuri showed slowly spread pattern 
 75% of patients the Neikuri showed fastly spread pattern. 
 10%% of patients the Neikuri showed Stand still (Not spread) 
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18.   HISTORY OF MASTURBATION 
Duration (years) Cases 
No Percentage (%) 
0 – 3 10 25% 
3-6 22 55% 
6-9 6 15% 
More than 10 years 2 5% 
TOTAL 40 100% 
Fig-18 
 
OBSERVATION: 
 Masturbation habit was present in 40 patients Out of these 25% were within 0 
to 3 years duration, 55% were within 3 years to 6 years duration 
 15% patient was within 6 to 10-year duration. Remaining 2.5% were more   
than 10 years duration.  In all the 40 patients the frequency of masturbation 
was once in 3 days or weekly twice. 
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19. CLINICAL FEATURES 
 
Symptoms No of 
cases 
Before 
treatment 
Percentage (%) 
No. of 
cases 
After 
treatment 
Percentage (%) 
Premature ejaculation 18 45% 3 7.5% 
Erectile dysfunction 33 80% 5 12.5% 
Painful coitus 0 0 0 0 
Painful Micturition 7 17.5% 1 2.5% 
Nocturnal emission 10 30% 2 5% 
Scrotal swelling 0 0 0 0 
Fig-19: 
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OBSERVATION: 
 Premature ejaculation is the commonest symptom in infertility patients. 45% 
of patients suffered with this complaint. These patients were not fully satisfied 
during intercourse. 7.5% the patients were improved after the treatment. 
 80% Patients came with erectile dysfunction, but not persistent. 12.5% the 
patient was improvement after treatment. sometimes premature ejaculation 
and erectile dysfunction may be associated with painful coitus. 
 17.5%Patients came with painful micturition. 2.5%the patients were 
improvement after treatment. 
 Nocturnal emission is another important feature in infertility. Recurrent 
emission leads to decreased sperm count and motility. 30% patients came with 
this complaint, among them 5% were improved after the treatment. 
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20. SEMEN ANALYSIS- SEMEN COUNT IMPROVEMENT PROFILE 
Semen Count 
Before treatment 
presenting with 
No of 
cases 
% Semen Count 
After treatment 
improved 
No of 
cases 
%  %    
Less than 5 Million/ml 5 12.5% Less than 5 Million/ml 0 0%    
More than 5Million -
10Million/ml 
6 15% More than 5Million -
10Million/ml 
2 5%    
More than 11Million-
20Million/ml 
7 17.5% More than 11Million-
20Million/ml 
3 7.5%    
More than 21Million-
30Million/ ml 
13 32.5% More than 21Million-
30Million/ ml 
6 15%    
More than 30 Million/ml 9 22.5% More than 30 Million/ml 29 72.5%    
 
Fig-20: 
 
OBSERVATION: 
 5% of patients improved after treatment within 5 Million 
 5% of patients improved after treatment more than 5Million to 10Million. 
 7.5% of patients improved after treatment more than 11Million to 20Million. 
 22.5% of patients improved after treatment more than 21Million to 30Million 
 72.5%of patients improved after treatment more than 30 Million 
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21 SEMEN ANALYSIS -   ACTIVE MOTILITY IMPROVEMENT              
PROFILE 
Active Motility 
Before treatment 
presenting with 
No of 
cases 
% Active Motility 
After treatment 
improved by 
No 
of 
cases 
% 
Less than 5 % 6 12.5% Less than 5 % 2 5% 
More than 5% to 
10% 
8 20 More than 5% to 10% 4 10% 
More than 11% to 
20% 
11 27.5% More than 11% to 20% 3 7.5% 
More than 21% to 
30% 
11 27.5 More than 21% to 30% 6 15% 
More than 30 % 4 10% More than 30 % 25 62.5% 
 
Fig-21: 
 
OBSERVATION: 
 5% of patients improved after treatment with Active Motility less than 5% 
 10% of patients improved after treatment with Active Motility more than 5% to 
10%. 
 7.5% of patients improved after treatment with Active Motility more than 11% to 
20%. 
 15% of patients improved after treatment with Active Motility more than 21% 
to30%. 
 62.5% of patients improved after treatment with Active Motility more than 30%. 
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22.  PRIMARY OUT COME 
RESULT SPERM COUNT * No 
of 
cases 
% 
 
MOTILITY 
% # 
No of 
cases 
% 
 FROM TO FROM To 
GOOD ≤ 40 
million 
/ ejaculates 
≥ 60   
million 
/ ejaculates 
15 37.5 ≤ 50% ≥   
70 % 
 
10 25 
MODERATE ≤ 40    
million 
/ ejaculates 
> 50   
million 
/ ejaculates 
4 12.5 ≤ 50% ≥ 60 
% 
 
16 40 
MILD ≤ 40    
million 
/ ejaculates 
50 million 
/ ejaculates 
7 17.5 ≤ 50% > 50 
% 
 
4 10 
POOR 1    million 
/ ejaculates 
≤ 40    
million 
/ ejaculates 
14 35 ≤ 50% ≤ 
50% 
10 25 
 
 
Reference: 
 As per 1999 WHO criteria (1) standard value for total number of spermatozoa 
≥ 40 million   per ejaculates. 
 As per 1999 WHO criteria (1) standard value for motility is ≥ 50 % million 
per ejaculates. 
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Fig-22: 
 
OBSERVATION:  Primary out come regarding sperm count 
 37.5% of the patients falling into the category GOOD- increase of sperm count 
with range of 40-60Million/ml. 
 12.5% of the patients falling into the category MODERATE- increase of sperm 
count with range of 40 to more than 50Million/ml. 
 17.5% of the patients falling into the category MILD- increase of sperm count 
with range of 40-upto 50Million/ml. 
 35% of the patients falling into the category POOR- with the range of sperm 
count below 40Million/ml. 
 
Primary out come regarding Active Motility 
 24% of the patients falling into the category GOOD- increase of Active Motility 
with range of 50%-70%. 
 41% of the patients falling into the category MODERATE- increase of Active 
Motility with range of 50 %to 60%. 
 10% of the patients falling into the category MILD- increase of Active Motility 
with range of with 50%. 
 25% of the patients falling into the category POOR-   with range of Active 
Motility within 50%. 
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STATISTICAL ANALYSIS 
All collected data were entered into MS Excel software using different columns as 
variables and rows as patients. STATA software was used to perform statistical 
analysis. Basic descriptive statistics include frequency distributions and cross-
tabulations were performed. Bar diagram are used to describe the value of different 
variables for pictorial representation. The quantity variables were expressed as mean 
standard deviation and qualitative data as percentage. A probability value of <0.05 
was considered to include as statistical significance. Paired t test was performed for 
determining the significance between and after treatment. 
 
Results of statistical analysis of objective parameters (semen analysis) before and 
after treatment of 40 patients of Aan maladu. 
Sno Parameter Mean 
Probability value(p) t value 
BT AT 
1 Sperm 
count 
21.01 60.6 
0.0001 4.63 
2 Sperm 
motility 
23.25 36.75 
0.0001 5.04 
 
Results of statistical analysis of subjective parameters before and after 
treatment of 40 patients of Aan maladu. 
The mean + Standard deviation of sperm count before and after treatment were 
21.01 and 60.6 respectively which is statistically significant (t=4.63 P<1.0000. 
 
The mean + Standard deviation of sperm motility before and after treatment were 
23.25 and 36.75 respectively which is statistically significant (t=5.04 P<1.0000. 
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DISCUSSION 
 
In developing country likeIndia, one in every four couples found to be affected 
by infertility. In 2010 almost 50 million couple’s world wide unable to have a child 
after five years of marriage. Infertility rate has hardly changed over the past 20 years. 
The global health community has made great success in improving the infertility care 
in the past decade. Infertility can lead to distress and depression as well as 
discrimination and ostracism. infertility can be caused by poor sexual life style habits 
that are easily remedied. Heavy usage of alcohol, tobacco drugs, tight underwares or 
pants which raise the scrotal temperature and reduce the sperm count. Infections play 
a vital role in male infertility that block the ducts through which the sperm travels. 
Exposure to metals such as lead, chemical and pesticide plays a major role in male 
infertility. Auto immunity in which antibodies or cells of the human immune system 
attack sperm cells mistaking them as toxic invaders. Nowa day’s male 
infertilitytreatmeant is a challenging task. In recent years siddha system of medicine 
have bloomed up in treating male infertility with high success rate.  
 There was a time when infertility was only limited to women but in present 
scenario male infertility is blamed in 59% of cases where couples could not conceive 
naturally. Most of the cases hail from IT back ground. The change in life style even 
among small income group has led to increase in infertility rate and lack of physical 
activities. Any infections that occur at an early age in a male child and low economic 
standards can also lead to rise in male infertility.   
 The most common problems men face is low sperm count, low motility rate 
and morphological abnormalities. The reproductive age for men is 18 to 50  
Age Distribution: 
Among 40 cases   
 5% cases are between the age group of 20-25yrs 
 15% cases are between the age group of 25-20yrs 
 62.5% cases are between the age group of 31-35yrs 
 15% cases are between the age group of 36-40yrs 
 2.5%cases are between the age group of 41 -45yrs  
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Inference: 
 In my study the prevalence of the disease was found to be more in the 
age growth ranging from 31years to 35years (62.5%) 
Occupational history: 
 Out of 40 patients 45% patients were working in hot atmosphere.IT 
Profession 12Patients (30%), businessman7patients [17.5] Drivers (15. 
0%).working in hot atmosphere. 
 This plays a vital role in male infertility. This may be one of the causes 
for infertility. 
Food habits 
 Out of 40 patients 36(90%) were non-vegetarian and 4(10%) were 
vegetarian. 
  This dietary style is more prone for developing infertility 
Personal habits 
 Out of 40 patients 15[37.5%] patients were with none of the above 
habits 
 15[37.5%] patients were with smokers ans social drinkers. 
 10[25%] patients were with only smokers.  
Marital status 
 Among 40 cases 36cases (90%) were married remaining 4 cases were 
unmarried 
Socio economic status 
 Out of 40 cases 
 Upper class group                 -21 cases (52.5%) 
 Middle class group                 -10 cases (25%) 
 Lower class group                   -9 caese (22.5%) 
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Inference: 
 In this study most of the patients coming from upper class group 21 cases 
(52.5%) 
Duration of Male Infertility 
 50% of patients were within 0-3 years duration of infertility. 
 25% of patients were within 4years to 6 years of infertility. 
 20% of patients were within7yeara to 9years of infertility. 
 5% of patients were more than 10 years of infertility., 
Inference: 
 In this study most of the cases 20 (50%) were within 0-3 years duration of 
infertility 
Thinai: 
 12.5% of patients came from Maruthamthinai. 
 7.5%of patients from Mullaithinai. 
 77.5%of patients fromNeithalthinai. 
 2.5% of patients from kurunjithinai. 
Inference 
 In this study most of the cases 31(77.5%) patients coming from 
neithalthinai.. 
Paruvakaalam: 
 100% of the patients came in pinpanikalam. 
  The body which is already been weak due to the effect of previous 
season.  
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Thegi: 
 30% of patients presenting with VathaThegi. 
 45% of patients presenting with PithaThegi. 
 25% of patients presenting with KabaThegi. 
 Pithathegi are more prone to male infertility. 
Three Humors: 
 In Vatham 60% of patients (abannan) was affected due to pre-mature 
ejaculation, nocturnal ejaculation, burning micturition. 
 In Pitham 100%of patients (Sathagampitham) was affected due to 
decreased sperm count, decreased sperm motility. 
 InKabam65% of patients (Tharpakam) was affected due to burning 
sensation of eyes. 
 In Saamanan 20% of patients was affected. 
Kosam (Five sheaths) 
 In 100%of the patientsAnnamayakosam was affected. (Two of the 
physical constituents saaram and senner affected). 
 70% of the patients ManomayaKosam was affected. (depression, 
Insomnia). 
 100%of the patients AnandhamayaKosam was affected. (decreased 
sperm count and motility).   
 
UdalThathukkal 
 Saram was affected in 100% patients. 
 Senneer was affected in 100% patients. 
 Sukkilam was affected in 100% patients 
 Derangement of Saaram, Senneer, sukkilam or any one of this lead to 
development of infertility.  
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Envagaitheryu 
Naa: 
 12.5% of patients presenting with Dryness of tongue. 
 
Sparisam: 
 Sparisam was Veppam in 27.5%patients due to working in hot 
atmosphere. 
 Sparism was Methavepam in 72.5%patients. 
Moothiram:  
 moothiram was affected in 17.5% patients (burning micturition). 
Naadi: 
 -32.5% of the patients were presenting withVathaPithamNaadi. 
 67.5% of the patients were presenting withPithaVathamNaadi. 
Sukkilam: 
Buoyancy on water: The important Siddha parameter to evaluate the Sperm.In 10% 
of the patient’s sperm were floating on water indicating abnormal condition. 90% of 
the patients presented sperms not were floating on water indicating normal condition. 
 
Neerkuri 
The important Siddha diagnostic parameter. 
 35% of patients the colour of the urine was pale yellow colour. 
 10% of the patients the colour of the urine wasyellow colour. 
 7.5% of the patients the colour of the urine was dark yellow in colour. 
 47.5% of the patients the colour of the urine was straw coloured urine. 
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Neikuri 
 An important Siddha parameter reflecting the signs of Prognosis is spreading pattern 
of the in the urine. 
 15% of patients the Neikuri showed slowly spread pattern. 
 75% of patients the Neikuri showedfastly spread pattern. 
 10%% of patients the Neikuri showed Stand still (Not spread) 
 History of Masturbation 
 Masturbation habit was present in 40 patients Out of these 25% were 
within 0 to 3 years duration. 
 55% were within3 years to 6 years duration. 
 15% patient was within 6 to 10-year duration.  
 Remaining 2.5% were more than 10 years duration.    
 In all the 40 patients the frequency of masturbation was once in 3 days 
or weekly twice. 
Clinical Features  
 Premature ejaculation is the commonest symptom in infertility 
patients. 45% of patients suffered with this complaint. These patients 
were not fully satisfied during intercourse. 7.5% the patients were 
improved after the treatment. 
 80% Patients came with erectile dysfunction, but not persistent. 12.5% 
thepatient was improvement after treatment. sometimes premature 
ejaculation and erectile dysfunction may be associated with painful 
coitus. 
 17.5%Patients came with painful micturition. 2.5%the patients 
wereimprovement after treatment. 
 Nocturnal emission is another important feature in infertility. 
Recurrent emission leads to decreased sperm count and motility. 30% 
patients came with this complaint, among them 5% were improved 
after the treatment. 
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Semen analysis- Semen Count After treatment improvement profile 
 5% of patients improved after treatment within 5 Million / ml 
 5% of patients improved after treatment more than 5Million to 10Million. 
 7.5% of patients improved after treatment more than 11Million to 20Million. 
 22.5% of patients improved after treatment more than 21Million to 30Million 
 72.5%of patients improved after treatment more than 30 Million  
 
Semen analysis -Active Motility After treatment improvement profile 
 5% of patients improved after treatment with Active Motility less than 
5% 
 10% of patients improved after treatment with Active Motility more 
than 5% to 10%. 
 7.5%of patients improved after treatment with Active Motility more 
than 11% to 20%. 
 15% of patients improved after treatment with Active Motility more 
than 21% to30%. 
 62.5%of patients improved after treatment with Active Motility more 
than 30%. 
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PRIMARY OUTCOME OF THE TREATMENT WITH THE TRAIL DRUG 
THATHU VIRUTHI KULIGAI 
Primary out come regarding sperm count 
 37.5% of the patients falling into the category GOOD- increase of 
sperm count with range of 40-60Million/ml. 
 12.5% of the patients falling into the category MODERATE- increase 
of sperm count with range of 40 to more than 50Million/ml. 
 17.5% of the patients falling into the category MILD- increase of 
sperm count with range of 40-upto 50Million/ml.  
 35% of the patients falling into the category POOR- with the range of 
sperm count below 40Million/ml.  
Primary out come regarding Active Motility 
 24% of the patients falling into the category GOOD- increase of 
Active Motility with range of 50%-70%. 
 41% of the patients falling into the category MODERATE- increase 
of Active Motility with range of 50 %to 60%. 
 10% of the patients falling into the category MILD- increase of Active 
Motility with range of with 50%. 
 25% of the patients falling into the category POOR-   with range of 
Active Motility within 50%. 
 In clinical study, out of 40 patients 37 patients (92.5%) were showed 
improvement in clinical lab investigation (semen analysis). The sperm 
count and sperm motility were improved in those patients. All the 37 
patients (92.5%) were relived from clinical symptoms. 
 The sperm count and sperm motility differences before and after 
treatment showed statistically significant in Male infertility patients. 
 The mean + Standard deviation of sperm count before and after 
treatment were 21.01 and 60.6 respectively which is statistically 
significant (t=4.63 P<1.0000. 
 The mean + Standard deviation of sperm motility before and after 
treatment were 23.25 and 36.75 respectively which is statistically 
significant (t=5.04 P<1.0000. 
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SUMMARY 
The main aim of this study is to document the effectiveness of siddha 
medicine thathuviruthikulikai (Internal medicine) in the management of 
AANMALADU (Male infertility). 
 
The objective of this study is the Clinical studies conducted in 40 cases. The raw 
drug was purchased from reputed country medical shop in Chennai and drug 
authentication by Assisstant Professor of Medicinal Botany. 
 
The drug was prepared as per standard operating procedure mentioned in the 
siddha literature in Gunapadam laboratory of National Institute of Siddha. 
 
The standardization of study drug was carried out in the Biochemistry lab of 
NIS.It revealed the presence of chloride, fluoride, carbonate with the study drug 
 
The clinical study was conducted with a well-defined protocol and a proper 
proforma after getting the approval of the Institutional Ethical Committee. (IEC 
NO.2016/11-04/14.10.2016] 
  
The study data were registered in CTRI (Clinical Triall Registry of India) with ID 
NO: CTRI/2018/01/011580 
 
After screening 60 cases study based on the inclusion criteria and exclusion 
criteria reporting at the OPD of Maruthuvam, 40 cases were selected for induction to 
the study. Before enrolment into the trial the informed consent was obtained from the 
patients. 
 
The aim of the study is to increase the sperm count and sperm motility in male 
infertility patients. The duration of administration of study drug 48 days. The study 
drug dose was illanthaikottaialavu [325mg] twice a daily with cow milk 
 
Before Starting the treatment semen analysis, routine blood and urine examination 
were taken in all 40 patients. Siddha methods like three Humor, Thegi, Kosangal, 
udalthathukkal, Envagaithervu, neeikuri, nerkuri and buoyancy of Semen on water 
were analysed in all 40 Cases. 
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Patients were instructed to come for clinical assessment once in 15 days. They 
were also instructed to bring back the unconsumed drug during the next visit and 
return the same. In every visit the clinical assessment was made. 
 
At the end of the treatment reduction of clinical symptoms and improvement in 
clinical lab para meters (Sperm count and motility) in all the 40 patients. 72.5% of 
patients improved after treatment more than 30 Million in sperm count.24% of the 
patients were presenting increase of Active Motility with range of 50%-70%. 41% of 
the patients were presenting increase of Active Motility with range of 50 %to 
60%.10% of the patients were presenting increase of Active Motility with range of 
with 50%. 25% of the patients were presenting with range of Active Motility with less 
than 50%.  
 
The cost of medicine is comparatively low. The ingredients were easily available 
and the rural people will be benefited more. 
 
The mean + Standard deviation of sperm count before and after treatment were 
21.01 and 60.6 respectively which is statistically significant (t=4.63 P<1.0000. 
 
The mean + Standard deviation of sperm motility before and after treatment were 
23.25 and 36.75 respectively which is statistically significant (t=5.04 P<1.0000. 
 
I have concluded the siddha medicine thathuviruthikulikai was effective in 
treatment of ―Aanmaladu‖ (Male infertility especially oligospermia and 
asthenozoospermia). 
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CONCLUSION 
 
 The trail drug thathuviruthikuligai on administrating to 40 patients for 48days 
have improved the quality of semen in count and motility.  
 Expenditure of the study drug is cost effective, easily preparable and highly 
effective in Aanmaladu. 
Sperm Count: (Ref:As per 1999 WHO criteria) 
 Sperm count have improved to Good result by 37.5% 
 Sperm count have improved to Moderate by 12.5% 
 Sperm count have improved to Mild by 17.5% 
 Sperm count falling with the Poor criteria by 35% 
 
 Sperm Motolity: (Ref:As per 1999 WHO criteria) 
 Sperm motility have improved to Good result by 24% 
 Sperm motility have improved to Moderate by 41% 
 Sperm motility have improved to Mild by 10% 
 Sperm motility falling with the Poor criteria by 25% 
 
 Initially 50% of patients were affected from secondary sexual characters like 
premature ejaculation,erectile dysfunction,nocturnal emission, Painful 
micturition. Among them 44.4% were improved after the treatment. 
 The effectiveness of the drug was assessed by the improvement of the patients 
from low sperm count, low motility which is measured using assessment 
score. 
 Inference: The test drug is statistically significant (p>0.0001) and hence it is 
effective in the treatment of Aanmaladu. 
 No adverse drug reactions were noticed during the course of treatment 
 Because of the encouraging clinical and laboratory results, the study may be 
undertaken with the same medicines for a prolonged period in a large number 
of cases for the treatment of Aanmaladu.     
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DEPARTMENT OF MARUTHUVAM 
CLINICAL STUDY ON “AAN MALADU” (MALE INFERTILITY) AND THE DRUG OF 
CHOICE IS“THATHU VIRUTHI KULIGAI” 
FORM I SCREENING & SELECTION PROFORMA 
 
REG NO:  
 
1. STUDY  NO______    2 OP NO:__________ 
 
3.NAME :______________________________ 4. AGE/SEX________5.RELIGION: H / C / M / O 
 
6.OCCUPATION / INCOME: ____________ 
 
 INCLUSION CRITERIA 
1. Male infertility 
2. Age 21- 45 year 
3. Maritial status -  more than 1 year 
4. Sperm count <40 Millions/Ejaculation 
5. Motility less than < 50 % 
6. Patient willing to sign the informed consent stating that he will conscientiously stick to the 
treatment during 48days but can opt out of the trial of his own conscious discretion. 
7. Patients who are willing to give specimen of blood, urine and semen before and after the 
treatment 
EXCLUSION CRITERIA 
1. Azoospermia 
2. Hydrocele 
3. Diabetes mellitus 
4. Endocrine disorders 
5. Hypertension 
6. Caridiac diseases 
7. VDRL & STD 
8. Inguinal Hernia 
9. Renal diseases 
10. Varicose veins 
11. Systemic illness 
ADMITTED TO TRAIL:    YES           NO         If Yes Serial NO:  
Date: 
 
Station: 
 
Signature of the Investigator:                                                        
 
Signature of the Lecturer:      
         
        Signature of the HOD 
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NATIONAL INSTITUTE OF SIDDHA, CHENNAI – 47 
AYOTHIDOSS PANDITHAR HOSPITAL 
DEPARTMENT OF MARUTHUVAM 
CLINICAL STUDY ON “AAN MALADU” (MALE INFERTILITY) AND THE DRUG OF CHOICE IS 
“THATHU VIRTHI KULIKAI” 
FORM lI CLINICAL ASSESSMENT FORM 
 FORM 
REG NO:  
1. Study No: ________________   2. OP No: ________________________________ 
 
3. Name: ___________________________________ 
 
  4. Gender: Male 
 
5. Age (years): _______________DOB    
      Date       Month            Year 
6.Address: ______________________________ 
                   _______________________________ 
                  ______________________________ 
                  _______________________________    
7.A. Occupation: --------------------------------    B. Nature of work--------------------------- 
 
8. Educational Status: A) Illiterate        B) Literate        9. Marital status-     
 
10. Complaints and Duration:   
________________________________________________________________________ 
 
________________________________________________________________________ 
11. Habits of 
 
A) Smoking  1. Yes; duration ________ years; Number - 2. No 
B) Alcoholism  1. Yes; duration ________ years; Quantity-   ml 2.No 
C) Tobacco chewing 1. Yes; duration ________ years; 2. No 
D) Betel chewing 1. Yes; duration ________ years;  2. No 
E) Drugs- 
 
12.Dietry style A. Pure vegetarian           B. Non-vegetarian            C. Mixed diet 
 
13.Treatment History:  
Had the patient been treated before with fertility drugs? A) Yes            B) No 
14.Previous history:     
Past Medical history (Yes/No) 
Past Surgical history (Yes/No) 
Past Infertility history (Yes/No) 
 
 If yes-------------------------- 
 
Initial (1
th
 day) 18
th 
day          33
th day
        48
th
 day      
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SIDDHA SYSTEM OF EXAMINATION 
 
1. ENNVAGAI THERVU: [EIGHT-FOLD EXAMINATION] 
 
 I. NAADI: [PULSE PERCEPTION] 
NAADI 0
TH
 DAY 18
TH
 DAY 33th DAY 48
th
 DAY 
VATHAM     
PITHAM     
KABAM     
VATHAPITHAM     
VATHAKABAM     
PITHAVATHAM     
PITHAKABAM     
KABAVATHAM     
KABAPITHAM     
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II. NAA: [TONGUE] 
 
 
 
III.NIRAM: [COMPLEXION]    
 
0
th
 day 18
th
 day 33th day 48
th
 day 
Dark 
yellowtinted/wheatis
h brown/pale 
Dark 
yellowtinted/wheatis
h brown/pale 
Dark 
yellowtinted/wheatis
h brown/pale 
Dark 
yellowtinted/wheatishbrown/pa
le 
 
 
IV.MOZHI: [VOICE] 
 
 
 
 
 
 
 
 
 
 
 
0th Day 18th Day 33th Day 48th Day 
Colour Dark / 
Yellow/ 
Red / Pale/ 
Normal 
 
Dark / 
Yellow/ 
Red / Pale/ 
Normal 
 
Dark / 
Yellow/ 
Red / Pale/ 
Normal 
 
Dark / 
Yellow/ 
Red / Pale/ 
Normal 
 
Taste Sweet/ 
Bitter / 
Sour 
Pungent/ 
None 
Sweet/ 
Bitter / 
Sour 
Pungent/ 
None 
Sweet/ 
Bitter / 
Sour 
Pungent/ 
None 
Sweet/ 
Bitter / 
Sour 
Pungent/ 
None 
Coating Present/ 
Absent 
Present/ 
Absent 
Present/ 
Absent 
Present/ 
Absent 
Fissure Present/ 
Absent 
Present/ 
Absent 
Present/ 
Absent 
Present/ 
Absent 
Saliva Normal/ 
Increased/ 
Decreased 
Normal/ 
Increased 
Decreased 
Normal/ 
Increased/ 
Decreased 
Normal/ 
Increased/ 
Decreased 
Dryness Present/ 
Absent 
Present/ 
Absent 
Present/ 
Absent 
Present/ 
Absent 
Glossitis Present/ 
Absent 
Present 
/Absent 
Present/ 
Absent 
Present/ 
Absent 
Baldness Present/ 
Absent 
Present/ 
Absent 
Present/ 
Absent 
Present/ 
Absent 
0
th
 Day 18th day 33th  Day 48th Day 
Medium/ 
High/ 
Low pitched 
Medium/ 
High/ 
Low pitched 
Medium/ 
High/ 
Low pitched 
Medium/ 
High/ 
Low pitched 
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V.VIZHI: [EYES] (Lower palpabrel conjunctiva)   
 
 
 
 
 
 
 
 
VI. MALAM; [BOWEL HABITS / STOOLS] 
 
 0
th
 Day 18
th
 Day 33
th
 Day 48
th
 Day 
Colour Dark/ 
Yellow/ 
Pale/Others 
Dark/ 
Yellow/ 
Pale/Others 
Dark/  
Yellow 
Pale/Others 
Dark/ 
Yellow/ 
Pale/Others 
Consistency Solid/ 
Semisolid 
Watery 
Solid/ 
Semisolid 
Watery 
Solid/ 
Semisolid 
Watery 
Solid/ 
Semisolid 
Watery 
Stool bulk                          Normal/
Reduced 
Normal 
/Reduced 
Normal/ 
Reduced 
Normal/ 
Reduced 
Constipation   Present/ 
Absent 
Present/ 
Absent 
Present/ 
Absent 
Present/ 
Absent 
Diarrhoea Present/ 
Absent 
Present/ 
Absent 
Present/ 
Absent 
Present/ 
Absent 
 
 
7.URINE EXAMINATION 
 
 
 
 
 
 
 
 
   
 
 
 
 
 
 
 
 
 
 
 
0
th
 Day 18th day 33°  Day 48
th
 day 
Yellow 
Red 
/ Pale/Normal 
Yellow 
Red/ 
Pale/Normal 
Yellow 
Red/ 
Pale/Normal 
 
NEER 
KURI 
0
th
 Day 18
th
 Day 33 
th
 Day 48
th
 Day 
Niram 
[Colour]   
White/ 
Yellowish/ 
Straw 
coloured/ 
Crystal 
clear 
White/ 
Yellowish/ 
Straw coloured/ 
Crystal clear 
White/ 
Yellowish/ 
Straw coloured/ 
Crystal clear 
White/ 
Yellowish/ 
Straw coloured/ 
Crystal clear 
Manam 
[Odour] 
Present/ 
Absent 
Present/ 
Absent 
Present/ 
Absent 
Present/ 
Absent 
Nurai 
[Froth] 
Nil/ 
Reduced/ 
Increased 
Nil/ 
Reduced/ 
Increased 
Nil/ 
Reduced/ 
Increased 
Nil/ 
Reduced/ 
Increased 
Edai 
[Sp.gra]                            
Normal/ 
Increased/ 
Reduced 
Normal/ 
Increased/ 
Reduced 
Normal/ 
Increased/ 
Reduced 
Normal/ 
Increased/ 
Reduced 
Enjal 
[Deposits] 
Present/ 
 Absent 
Present/ 
 Absent 
Present/ 
 Absent 
Present/ 
 Absent 
Volume   Normal/ 
Increased/ 
Reduced 
Normal/ 
Increased/ 
Reduced 
Normal/ 
Increased/ 
Reduced 
Normal/ 
Increased/ 
Reduced 
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VIII.SPARISAM: [PALPATORY PERCEPTION] 
 
 
0
th
 Day 18thDay 33thDay 48TH Day 
Warmth/ 
Cold/ 
Normal/ 
Sweat 
Warmth/ 
Cold/ 
Normal/ 
Sweat 
Warmth/ 
Cold/ 
Normal/ 
Sweat 
Warmth/ 
Cold/ 
Normal/ 
Sweat 
 
THEGI: [ TYPE OF BODY CONSTITUTION]  
  
Vatham predominant  Kabam predominant 
Pitham predominant  Thondha udal 
 
6.NILAM: [ LAND WHERE PATIENT LIVED MOST] 
 
1.Kurinji (Hilly terrain)   
2.Mullai (Plains)                 
3.Marutham (Forestrange)                 
4.Neithal (Coastal belt)              
5.Palai (Aridregions)     
 
 
7. KAALAM 
 
Kaarkalam   Pinpanikalam      
Koothirkalam   Ilavenil 
Munpanikalam   Muthuvenil 
 
8. GUNAM 
Sathuvam                        Rasatham                       Thamasam 
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IMPORIGAL (SENSORY ORGANS) 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
KANMENTHIRIYAM (MOTOR ORGANS) 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 0
th
 
day 
18th day 33th day 48thday 
Mei  
(Skin) 
    
Vaai 
(Buccal 
Cavity) 
    
Kann 
 (Eye) 
    
Mooku 
(Nose) 
    
Sevi(Ear)     
Kanmenthiriyam  0
th
 
day 
18
th
 day 33
th
 day 48
th
 day 
Kai (upper limb)     
Kaal (lower limb)     
Vaai (buccal cavity)     
Eruvai (excretory 
organs) 
    
Karuvai 
(reproductive organs) 
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KOSANGAL(Sheath)    
 
Kosangal 
 
0
th
 day 18
th
 day 33
th
 day 48
th
 day 
Annamaya Kosam 
 
    
Pranamaya kosam     
Manomaya kosam      
Vignanamaya kosam  
 
    
Ananthamaya kosam     
 
MUKKUTRAM: [AFFECTION OF THREE HUMORS] 
A) VATHAM: 
 
 
Vatham  0
th
 day 18
th
 day 33
th
 day 48
th
 day 
Praanan     
Abaanan     
Samaanan     
Udhaanan     
Viyaanan     
Naagan     
Koorman     
Kirukaran     
Devathathan     
Dhananjeyan     
 
B) PITHAM: 
 
Pitham 0
th
 day 18
th
 day 33
th
 day 48
th
 day 
Analapitham     
Prasakam     
Ranjakam     
Aalosakam     
Saathakam     
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C) KABAM: 
 
Kabam  0
th
 day 18
th
 day 33
th
 day 48
th
 day 
Avalambagam     
Kilethagam     
Pothagam     
Tharpagam     
Santhigam     
 
 
13. SEVEN DHATHUS: (7 SOMATIC COMPONENTS)  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
14. GENERAL EXAMINATION: 
 
General Examination: 
 
0
th
 day 18
th
 day 33th day 48
th
 day 
Height (cms)     
Weight (kg)     
Temperature(°F)       
Pulse rate (pe rmin)     
Heart rate (per min)     
Respiratoryrate(permin)     
Blood pressure(mm/Hg)     
Pallor     
Udal thathukkal  0
th
 day 18
th
 day 33
th
 day 48
th
 day 
Saaram[Chyme]     
Senneer[Blood]      
Oon[Muscle]     
Kozhuppu[Fat]     
Enbu[Bones]     
Moolai 
[Bonemarrow] 
    
Sukkilam/Suronitha
m [Genital 
discharges] 
    
139 
 
Jaundice     
Cyanosis     
Lymphadenopathy     
Pedal edema     
Clubbing     
Jugular venous pulsation     
 
15. SYSTEMIC EXAMINATION: 
 
 
 
17. CLINICAL SYMPTOMS 
 
 
 
 
 
 
 
 
 
 
 
 
 
Date: 
Station: 
Signature of the Investigator:         Signature of the Lecturer: 
    
 
     Signature of the HOD 
 
Systemic examination 0
th
 day 18
th
 day 33th day 48
th
 day 
Locomotor system     
Cardio Vascular System  
 
   
Respiratory system       
 
   
Gastro Intestinal system     
 
   
Central Nervous System         
 
   
Urogenital system     
Endocrine System     
S.no CLINICAL 
SYMPTOMS 
0
th
 
day 
18
th
 
day 
33th 
day 
48
th
 
day 
1 Premature 
ejaculation 
    
2 Nocturnal emission     
3 Erectile dysfunction     
4 Painful coitus     
5 Painful micuturition     
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NATIONAL INSTITUTE OF SIDDHA, CHENNAI – 47 
AYOTHIDOSS PANDITHAR HOSPITAL 
DEPARTMENT OF MARUTHUVAM 
CLINICAL STUDY ON “AAN MALADU” (MALE INFERTILITY) AND THE DRUG OF CHOICE IS 
“THATHU VIRUTHI KULIGAI” 
 
       FORM III 
LABORATORY INVESTIGATION ON ENROLLMENT
  
 
1. STUDY  NO______    2 OP NO_____________:  REG NO:  
 
3.  NAME_____________________   4. DATE OF ASSESSMENT: ------------  
 
  
BLOOD INVESTIGATION NORMAL VALUES 
BEFORE  
TMT 
 
AFTER  
  TMT 
HB (gms%) 
M:13-18 
W:11-16 
  
 
T.RBC(million cells /cu.mm) 
M:4.5-6.5 
W:3.5-5.5 
  
 
ESR (mm) 
½ hr. 
M:0-10 
W:0-20 
  
1 hr.   
T.WBC (cells /cu.mm)       4000-11000   
DIFFERENTIAL 
COUNT (%) 
Polymorphs 40-75   
Lymphocytes 20-35   
Monocytes 2-10   
Esonophils 1-6   
Basophils 0-1   
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Blood Investigation Normal Values 
Before 
TMT 
 Date: 
After 
 TMT 
Date 
Blood 
glucose 
(mg/dl) 
Fasting 70-100   
PP 80-140   
Random 100-140   
Lipid 
profile 
(mg/dl) 
Serum cholesterol 150-250   
HDL 30-60   
LDL Upto 130   
VLDL 40   
TGL Upto 160   
RFT 
(mg/dl) 
Blood urea 16-50   
Serum creatinine 0.6-1.2   
Serum Uric acid 
M:3-9 
W: 2.5-7.5 
  
LFT 
(mg/dl) 
Total bilirubin 0.3-1   
Direct bilirubin 0.1-0.3   
Indirect bilirubin 0.2-0.8   
Serum total protein 6-8   
Serum Albumin 3.5-5.5   
Serum globulin 2-3.5   
Serum calcium 9-11   
Serum phosphorous 2-5   
SGOT (IU/L) 6-18   
SGPT (IU/l) 3-26   
Alkaline phosphatase 
mg/dl 
3-12   
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Special investigation: 
 
Semen analysis: 
 
 
 
 
 
Date : 
Station: 
Signature of the Investigator: 
 
Signature of the HOD    Signature of the Lecturer:
    
 
    
 
 
Before TMT (with Date) 
 
After TMT (With Date) 
 
Volume   
Colour   
Apperance   
Viscosity   
Liquefaction time   
Fructose   
Sperm count   
Motility   
Morphology   
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NATIONAL INSTITUTE OF SIDDHA 
AYOTHIDOSS PANDITHAR HOSPITAL, CHENNAI – 600 047. 
AND CLINICAL STUDY ON “AAN MALADU” (MALE INFERTILITY) AND 
THE DRUG OF CHOICE IS “THATHU VIRUTHI KULIGAI” 
FORM - IV (DRUG COMPLIANCE FORM) 
NAME:  
DRUG NAME:  
On 1
st
day-Date:     Drugs issued:      Drugs returned:  
On 12
th
 day-Date:     Drugs issued:      Drugs returned:  
On 36
th
 day-Date:              Drugs issued:      Drugs returned:  
On 48
th
 day-Date:            Drugs issued:      Drugs returned 
 
 
 
 
 
 
Day    Date    Morning   Evening   Day     Date    Morning   Evening 
Day 1    Day25    
Day2    Day26    
Day3    Day27    
Day4    Day28    
Day5    Day29    
Day6    Day30    
Day7    Day31    
Day8    Day32    
Day9    Day33    
Day10    Day34    
Day11    Day35    
Day12    Day36    
Day13    Day37    
Day14    Day38    
Day15    Day39    
Day16    Day40    
Day17    Day41    
Day18    Day42    
Day19    Day43    
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Date:          
Station: 
Signature of the Investigator: 
 
Signature of the Lecturer:       Signature of the HOD 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Day20    Day44    
Day21    Day45    
Day22    Day46    
Day23    Day47    
Day24    Day48    
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NATIONAL INSTITUTE OF SIDDHA, CHENNAI – 47 
AYOTHIDASAR PANDITHAR HOSPITAL 
DEPARTMENT OF   MARUTHUVAM 
Clinical Study on AAN MALADU (MALE INFERTILITY) and the drug of 
choice is“THATHU VIRUTHI KULIGAI”                                                                                                           
FORM V – INFORMATION SHEET 
Name of the Principal Investigator : Dr.P. MALAICHAMY 
Name of the Institution         : National Institute of Siddha, 
Tambaram Sanatorium, Chennai-47. 
 
Dr.P. Malaichamy Studying M.D(S) in National Institute of Siddha, Chennai. The 
disease called AAN MALADU (male infertility) symptoms like premature 
ejaculation, erectile dysfunction, nocturnal emission, painful coitus, painful 
micturition This condition is being treated in NIS with many siddha formulations. As 
a part of M.D(S) research programme and developing new efficacious medicines, I 
propose to study the thathu viruthi kuligai formulation for treating the condition. This 
formulation has been mentioned in siddha literature and empirical evidence with 
contemporary tools are required for documentation. You can receive medicines at free 
of cost. “thathu viruthi kuligai” can be taken twice daily with milk 48 days. The 
diagnosis tests will be carried out at free of cost. I will assess the effect of treatment 
after completion of 48 days of treatment using clinical and lab parameters. 
 
 In this regard, Ineed to ask you few questions. I will maintain confidentiality of 
your comments and data obtained from you. There will be no risk of disclosing 
your identity and no physical, psychological or professional risk is involved by 
taking part in this study. 
 
 Taking part in this study is voluntary. No compensation will be paid to you for 
taking part in this study. You can choose not to answer any specific question. 
There is no specific benefit for you if you take part in the study, but you will be 
under our clinical monitoring and specific attention will be given for your health. 
Taking part in the study may be of benefit to the community, as it may help us to 
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develop medicine for aan maldu.  In case of any adverse symptoms which is 
expected for few. patients during the treatment, shall be reported to Principle 
investigator and care will be taken in NIS for relief. You can withdraw from the 
study at the midst of treatment period, if you are not interested to continue and 
you will receive our regular out patient treatment without any condition. 
 
 The information we will collect in this study, will be kept confidential remain 
between you and the principal investigator. We will ask you a few questions 
through questionnaire. I will not write your name on other investigation forms 
which we will sent for different investigating/analysis sections and we will use a 
code instead given by the principal investigator. Only the principal investigator 
will know the key to this code which will be kept in safe custody. If you agree to 
be a participant in this study, you will be screened as per the study protocol.  
 
 If you wish to find out more about this study before taking part, you can ask me 
all the questions you want or contact Dr.p. Malaichamy PG scholar (Mobile phone 
no 9566988615 cum principal investigator of this study, attached to the National 
Institute of Siddha, Chennai. You can also contact the Chairman/Member-
secretary of Ethics committee, National Institute of Siddha, Chennai – 600047, 
Tel no: 91-44-22411611, for rights and participation in the study. 
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